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ABSTRACT
PATIENT-ORIENTED EVIDENCE-BASED
TREATMENT DECISION SUPPORT SYSTEM
(TREATQUEST®) FOR LUNG CANCER
by Danqing Hu
The University of Wisconsin-Milwaukee, 2013
Under the Supervision of Professor Hemant Jain.
Involving patients in healthcare decisions makes a significant and
enduring difference to healthcare outcomes. One challenge for patients is the lack
of evidence-based information and tools to support their decision making.
Although patients have access to significant information through internet and
other sources, it is not personalized for their specific situation. This dissertation
attempts to help patients acquire evidence-based information relevant to their own
situation, so they can make a more informed decision in co-operation with their
physicians. Lung cancer has been selected as a focus for this study because lung
cancer presents very complex decision making situation and is the leading cause
of cancer deaths in both men and woman in every ethnic group worldwide. The
prototype decision support system for lung cancer is called TreatQuest®. This
system allows users to create their own profile, access cases similar to their case,
and learn about treatment options. The evidences for the treatment were extracted
from public data and knowledge gained from guideline. The effectiveness of
patient-oriented evidence-based approach was validated by having a group of
patient use the system. TreatQuest® is one of the first system developed to
ii

support patient’s treatment decision process, which represent the most recent
trend in delivery of healthcare services. Results from this study show that such a
patient-oriented decision support system provides an effective way to help
patient receive more personalized information and make informed treatments. In
summary, patient-oriented evidence-based decision support systems such as
TreatQuest®, can improve the decision quality for patients. Also, such systems
can improve health care decisions that are made with the active participation of
fully informed patients. Therefore, patient-oriented evidence-based decision
support systems can have significant impact on the healthcare industry.
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Chapter 1 Introduction
1. 1 Problem Definition
Among many difficult decisions that the newly diagnosed cancer patients
have to make, the toughest and also the most important is which treatment should
be used. As the initial treatment bears critical consequence for the overall
treatment outcome, they almost have to make the best decision right away.
Unfortunately, these patients and their family will quickly realize that they are not
well prepared to make such a high-stake decision, even with the help from the
physicians. Most information from various educational materials or the Internet
tends to be general in nature, thus offers little help for their specific cases. On the
other hand, doctors usually make treatment decisions based on clinical practice
guidelines and their personal experience. Research has found a large variation in
their treatment practice due to the availability of clinical and demographic
information (Phillips-Wren et al., 2008 [1]) as well as sensitivity to patient
preference or physician and specialist supply (Starfield et al., 2005[2]; Wennberg
et al., 2003[3]).
One way to help new cancer patients is through developing a patientoriented treatment decision support system, which has actually become a new
trend in health care delivery. Different from the passive role many patients used to
take, patients today are better educated and more actively involved in treatment.
While a number of clinical decision support systems (CDSS) and clinical
knowledge management (CKM) systems have been established, their targeted
users are usually not patients. Instead, their goal is to serve healthcare service
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providers, such as physicians, hospitals staff, medical researchers, and members
of large healthcare organizations. What is in great need is a patient-oriented
support system that uses evidence-based information and industry guidelines to
help patients to communicate with their physician and to make informed
treatment decisions.
1. 2 Gaps in Research
A thorough survey was conducted for lung cancer treatment related
information on popular health-related websites, including WebMD, PubMed and
National Cancer Institute (NCI). As expected, these websites offer well-structured
information on symptoms, types, diagnosis, tests, treatment, and care. However,
no patient-oriented treatment related decision support function was found. Using
these websites, patients can further educate themselves on the disease but will not
be able to get information specific enough to their profile. Nor can they get
substantive help in selecting an appropriate treatment.
To investigate how much treatment decision support information is
available elsewhere, three popular medical support websites were examined. First,
the WebMD website offers a tool called Cancer Health Risk Check. Its main
function is to give a risk estimate for people who have not been diagnosed with
cancer, which clearly does not apply to patients already diagnosed. Second,
searching for treatment-related information for lung cancer was conducted on the
PubMed website. Keywords entered included lung cancer treatment, lung cancer
treatment decision support system, lung cancer treatment knowledge management
system, lung cancer treatment aid system, and lung cancer therapy. The results
returned were quite discouraging in that very few articles were found. The third
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source is the NCI website. This website offers not only general information on
different types of cancer but also summative information from Physician Data
Query (PDQ), a comprehensive cancer database. This database contains
summaries on a wide range of cancer topics, such as a registry of over 8,000 open
and over 19,000 closed cancer clinical trials from around the world, a directory of
professionals who provide genetics services, and the NCI dictionary of cancer
terms and drug dictionary. In addition, PDQ also provides cancer information
summaries in both patient and health professional versions for all kinds of cancer.
The patient version is written in less technical language than the health
professional version. While there is apparently abundant information on the NCI
website, it gives cancer patients no tool or service to acquire treatment
suggestions or recommendations based on their individual needs.
1. 3 Goals and Research Questions
To address the above gaps, this dissertation study builds a patient-oriented,
evidence-based treatment decision support system to help cancer patients to make
more informed decisions. This system aims to synthesize high-quality public data
with specific cases, offer analytical services, and provide patients with
information on multiple treatment options. The prototype system will focus on
lung cancer patients but can be easily extended to other types of cancer. This
system is named TreatQuest® to underscore its primary mission as the quest for
treatment information. Lung cancer patients are selected as the focus as it is the
leading cause of cancer deaths in both men and woman as well as in almost every
ethnic group worldwide. The American Cancer Society data show that in US
alone, there were 219,440 new lung cancer cases and 159,390 deaths from lung
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cancer in 2009 (Jemal et al 2009 [4]). Put into a different perspective, lung cancer
took 437 lives every day.
The primary goal of the TreatQuest® system is to integrate the vast
amount of information on cancer in an effective way so that users can easily
obtain information relevant to the characteristics of their specific case and to the
kind of decisions they are going to make. To achieve this, TreatQuest® system
acquires and process different types and levels of data and information. These
data include the raw statistical data (e.g. the SEER data), lung cancer treatment
information from relevant websites (e.g. WebMD). TreatQuest® also incorporate
the latest guidelines (e.g. the National Comprehensive Cancer Network (NCCN)
guidelines for lung cancer). Based on these data, functions are built to allow
patients to conduct queries for retrieving disease information, similar cases, and
various treatment options.
In the TreatQuest® system, the SEER data serves as the primary source.
This data offer a wide spectrum of demographic information from which almost
any patient will be able to find similar cases at both local and population levels.
By using data mining techniques, important information can be extracted under
various quest criteria. The retrieved information of similar cases can then be
integrated into summarized information at the current level. For example, using
the TreatQuest® system, a patient can easily look up similar cases. From there, if
the patient is not certain about the sequence of treatment options, he or she can
ask for information on the distribution of these similar patients on the sequence of
treatments, such as the percentage of patients receiving surgery first, receiving
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radiation therapy first, and receiving combined therapy. Specific information like
this will guide patients in selecting an appropriate treatment plan.
The focus of this study is on the development and evaluation of the
TreatQuest® system from both theoretical and practical perspectives.
Specifically, the following research questions are addressed:
1. How can a patient-oriented decision support system with evidencebased information and knowledge help patients to make informed
decisions?
2. How to develop a patient-oriented decision support system that is
based on large-scale data and industry guidelines?
3. How to evaluate the effectiveness of a patient-oriented decision
support system?
1. 4 Significance of the Study
Newly diagnosed cancer patients need both standardized and
customized information to make informed treatment decisions. While the
standardized information can be obtained from various guidelines, online
resources, and educational materials with considerable ease, the much-needed
customized information is hard to come by. The real power of the
TreatQuest® system lies in the high-quality customized information that it is
able to generate. Such a system will help to alleviate the stress and anxiety that
many patients experienced accumulate in searching for the optimal treatment
option. More importantly, it will present reliable unbiased medical information
in a language that patients can understand and use.
TreatQuest® can also complement the guidance and services that
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healthcare providers currently offer. This system will greatly improve
patients’ engagement and involvement, which has been shown to be
indispensable in cancer treatment. Utilizing a semi-structured decision support
system and the latest standards in evidence-based medicine, patients and
caregivers are in a good position to share the current and case-specific
information with the physicians, who in turn, will have better chance to
deliver the most appropriate treatment.
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Chapter 2 Literature Review
2.1 Patient Involvement as a Global Trend
The rapid advances of information technology along with the dramatic
social and legal changes in the healthcare industry have promoted a higher degree
of involvement of patients in the medical decision making process. As a result,
more and more research has been devoted to the question on how to increase
patient participation. According to a recent review published in the journal
Cochrane Database of Systematic Reviews, conducted in the United
States(Kinnersley et al., 2011[5]), patients who participated in informed decisionmaking were 20 percent less likely to choose costly surgery over medication than
other patients. In Belgium, an investigation of 128 advanced cancer patients in 13
hospitals (Pardon et al., 2009 [6]) revealed that almost all patients were interested
in obtaining more information on diagnosis, treatment, cure rate, and life
expectancy. Some patients also wanted information on palliative care (63.5%) and
end-of-life decisions (56.8%). This study clearly indicates that while the need of
patients may vary, they all want to be better informed. In Japan, a study
conducted by Watanabe and Takahashi (Watanabe et al., 2008 [7]), investigated
the actual preference of Japanese people on the involvement in treatment decision
making. Cancer patients recruited from a cancer self-help group in Tokyo were
interviewed on how they made decisions on cancer treatment. This study finds
that patients’ views on their preferred role in the decision making process can
vary substantially from complete physician control to complete patient control.
Overall, the patients with more control over their decision are more satisfied. One
key factor that affects the satisfaction level is how well the preferred involvement
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has been met by the actual involvement. This study suggests that to increase
patient satisfaction, healthcare professionals should assess individual patient
preferences first and provide healthcare services accordingly. Moreover, an
environment should be created to facilitate patients in expressing their
preferences.
A joint effort by researchers from Australia and the United Kingdom
(Gaston and Mitchell 2005[8]) systematically reviewed what information was
given to and what decisions were made by patients with advanced cancers. The
results show that almost all patients express the desire to be given all the
information. Meanwhile, about two-thirds expressed the interest in actively
participating in decision-making. Higher educational level, younger age and
female gender were indicative of stronger desire to participate. Active decision
making was also found to be more common in the patients with certain cancers
(e.g. breast) than others (e.g. prostate). This study concludes that the past 40 years
has witnessed a shift from treating patients as passive recipients to active
consumers who demand a higher level of autonomy. This study uncovers many
benefits of involving patients in health-care decisions, such as better compliance
with treatment and increased satisfaction of both patients and healthcare
providers. Possible disadvantages are the extra time and therefore higher cost,
inflated patient anxiety and regret in cases that an adverse outcome ensues as a
result of a patient-driven decision.
Researchers from the United Kingdom (Elwyn et al., 2000[9]) interviewed
experienced general practitioners on their attitude towards patient involvement in
decision making and on the necessary contextual factors, competencies, and
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stages to achieve satisfactory shared decisions. These clinicians listed
interpersonal skills and information requirements as major obstacles to shared
decision making. In addition, they viewed involvement as an implicit ethos that
should permeate medical practice. Their study result indicated that experienced
general practitioners with educational roles have positive attitudes to the
involvement of patients in decisions, provided the process matches the role
individuals wish to play. Besides that, Bekker (Bekker, 2010 [10]) studied how
the use of International Patient Decision Aids Standard (IPDAS) collaboration
checklist affected patients in making treatment choices. These authors show that
IPDAS has been promoted as an aid to help professionals engage in shared and/or
patient-centered care and its domain has been established mainly by experts’
opinions of best practice.
In summary, cancer patients have been shown to have a higher level of
desire and perceived participation in medical decision making than other patients
(Ernst et al., 2010 [11]). It is increasingly common for them to take a more active
role in the decision making process.
2.2 Shared Decision Making
The most commonly cited and generally accepted conceptualization of
shared decision making was defined by Charles (Charles et al., 1997[12]). These
authors define the key features of shared decision-making as ‘involvement of both
the patient and the doctor, a sharing of information by both parties, both parties
taking steps to build a consensus about the preferred treatment, and reaching an
agreement about which treatment to implement’. Over the past few decades, the
paternalistic health care style has gradually fallen out of favor. Instead, the
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patient-centered model has become a new norm (Stewart and Brown, 2001[13]).
The patient-centered model emphasizes patient autonomy, informed consent, and
empowerment.
The shared decision making (SDM) work is also part of the evidencebased medicine movement starting from the 1980s. This movement focuses on
providing evidence about medical alternatives to healthcare providers and patients
in order to improve their decision-making. This movement has received high level
of policy support in many countries (Coulter, 2001[14]; Coulter and Ellins, 2006
[15]). On the other hand, doubts have also been cast on whether the shared
decision-making can be applied to all patients (Brundage et al., 2005 [16]; Deber
et al., 2007 [17]; Edwards et al., 2005[18]). Other researchers have also
questioned its practicality in some situations (Berry, 2007[19]; Towle et al.,
2006[20]).
Shared decision-making has led to the birth of new organizations,
conferences, projects, and standards. For example, the primary mission of the
International Shared Decision Making (ISDM) Conference is to create ethical
standards for informed consent and to provide technology assessment for shared
decision making and patient-centered care (Margaret, 2008 [21]). The meetings of
the Society for Medical Decision Making and the International Society for
Technology Assessment in Health Care (ISTAHC) are extra venues for
researchers to share idea on SDM. Organizations such as the Institute for Health
Sciences (IHS) and European Association for Communication in Health Care
(EACH) have interests in shared decision making as well. As a collaborative
enterprise, the International Patient Decision Aid Standards (IPDAS) aims to
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identify research gaps, perform basic research in decision science and cognition,
support a set of criteria to be applied to patient decision tools, and stimulate
development of the field.
While increased patient involvement and shared decision-making have
been shown to be beneficial in many ways, such as better quality of care, higher
satisfaction for both patients and healthcare providers, and improved self-esteem
for patients (Crawford et al.,2002 [22]), in practice, they are not widely adopted
(Carlsen and Aakvik, 2006 [23]). Major barriers to their implementation include
attitudes, skills, and time availability for the providers (Gravel et al., 2006 [24]).
As always, decision-making process for health professionals is highly influenced
by personal preferences, experiences, relationships, and structural constraints
arising from class, education, ethnicity, and culture (Longo et al., 2006 [25]). On
the patients’ end, their experience may also vary by situation. Consequently, some
of them may take contradictory or ambivalent stands on assuming responsibility
for their health and health care at different times and/or different situations.
2.2.1 Physician’s Perspectives
Previous studies have found significant variability in how physicians view
the involvement of patients in medical decision making. First of all, not all
physicians favor patient involvement (Bruera et al., 2001 [26]). What is suggested
is that rather than forcing a uniform approach on all patients, physicians should
directly ask patients about their preferred level of involvement. Second, external
factors such as gender, geographical region, culture, and family background can
all exert influence on patient decision making (Baile et al., 2002[27]). For
example, women have been shown to be easier to discuss about hospice referral
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than men. They are less likely to withhold prognosis from the family. Lastly,
experienced general physicians with educational roles have more positive
attitudes towards the involvement of patients in decision making (Elwyn et al.,
2000 [28]) than those not engaged in education. These physicians are more ready
to take a cooperative approach in solving clinical problems.
In general, one consensus is to let patients decide how much information
should be shared and how much family involvement is appropriate. In practice,
providers should ask directly and early how the patient would like information to
be shared. This patient-focused approach not only empowers patients but also
relieves physicians from taking all the responsibility for the treatment outcome.
2.2.2 Patient’s Perspectives
Evidences suggest that patient’s preferences for receiving information on
treatments and for taking responsibility for treatment decisions vary as well.
Preference for a more active role is associated with increased level of education,
younger age, and female gender (Gaston and Mitchell, 2005[8]). Active decisionmaking was more common in patients with certain cancers (e.g. breast) than
others (e.g. prostate). Degner (Degner et al., 1997 [29]) has found that 22% of
women with breast cancer wanted to select their own treatment, 44% wanted to
select their treatment in collaboration with their physician, and 34% wanted to
delegate this responsibility totally to their physician. A post-treatment survey
found only 42% believed they had achieved their preferred level of control in
decision making and approximately 15% believed they had been pushed to
assume a more decisional role than they wanted.
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Researchers in Canada has also investigated the response of lung cancer
patients about their desired and actual levels of involvement in treatment decision
and about information needed for treatment decision-making (Davidson et al.,
1999 [30]). They found 43% of patients desired a collaborative role in their real
treatment decision at the beginning of treatment. After the treatment, 57% of
patients desired an active or collaborative role. Generally, patients wanted a wide
variety of information on treatment options. Types of information rated as
‘essential’ to treatment decisions were details of the treatment regimen, early and
late side-effects, survival, and effects of treatment on disease symptoms. These
findings are in sharp contrast with results from a study in Germany, where 60.2%
of patient actually desired a more passive role with hematological disease (Ernst
et al., 2010 [11]). In other words, the majority of the patients would rather leave
their medical decisions to physicians.
In conclusion, many cancer patients prefer an active role in their
treatment. The desire of involvement is affected by factors like disease type,
disease stage, age, gender, education level, as well as family involvement.
2.2.3 Evaluating Shared Decision Making
While SDM is viewed by many as the gold standard for medical care
(Charles et al., 1999 [31]) and there is evidence that SDM does lead to positive
patient outcomes (Gattellari et al., 2001 [32]; Fallowfield et al., 1990 [33]; Street
and Voigt, 1997[34]), others have argued that SDM is not always realistic or
preferred by patients (Butow et al., 2006 [35], Lam et al., 2003 [36]). As the
concept of SDM is relatively new, not many instruments have been published to
evaluate its effectiveness.
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SDM should be viewed as a flexible approach for patient participation
with different levels of applicability, contingent upon settings, time, and patient
preference (Mazur and Hickman, 1997[37]). With regard to measurement issues,
both generic and disease-specific instruments should be used to capture the results
from different angles(Miller, 1995 [38]). Generic instruments can be applied to
many types of diseases and may also be less costly (Deber, 1996 [39]). However,
changes in generic measures can be hard to interpret and they may not be
sensitive enough to detect small changes in specific populations or diseases
(Miller, 1995 [38]), which can be picked up by more specific instruments (Katon,
1981 [40]).
In recent years, a number of SDM coding systems and measures have been
published, such as the Decision Support Analysis Tool (DSAT) (Guimond,
2003[41]), the Observing Patient Involvement (OPTION) scale (Elwyn, 2003
[42]), the Decision Analysis System for Oncology (DAS-O) scale (Brown et al.,
2003 [43], the Shared Decision-Making Questionnaire (SDM-Q) (Simon et al.,
2006[44]), the Autonomy Preference index (API) (Ende et al., 1989 [45]), the
Control Preference Scale (CPS) (Degner and Sloan,1992 [46]), the Patients’
Perceived Involvement in Care Scale (PICS) (Lerman et al., 1990 [47]) and the
Combined Outcome Measure for Risk Communication and Treatment Decision
Making (COMRADE) (Edwards et al., 2003[48]). These coding systems share
common characteristics but each also has its own uniqueness.
Many behaviors were similarly coded in the OPTION, DAS-O and DSAT
systems. The DAS-O and OPTION coding systems explained a significant
moderate proportion of the variance in satisfaction with the doctors’ SDM
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skills(Butow et al., 2009[49]).The DSAT has been developed primarily to code
decision support provided outside the medical consultation, but many aspects of
this coding system relate to issues regarded as important in SDM within the
consultation, including presenting options, discussing the pros and cons of these
options, and eliciting patient preferences and values. According to Weiss et al
(Weiss and Peters, 2008[50]), DAS-O was strongly correlated with OPTION.
DSAT was moderately correlated with DAS-O and OPTION. Decisional
satisfaction and satisfaction with doctor SDM skills were significantly correlated
with OPTION and with DAS-O.
In general, these systems have not been able to deliver satisfactory results.
One possible reason is the variability in patient preferences for shared decision
making is confounded with whether or not they are satisfied with consultation
altogether. One exception is the satisfaction measures used in the oncology
setting, where highly skewed distributions have been observed with most patients
expressing extremely high satisfaction scores (Brown et al., 2008 [51]).
Since not all coding systems are equally valid, it is important to ensure
that optimal systems are used in analyzing doctor and patient behaviors.
Meanwhile, while shared decision making by nature involves both clinicians and
patients, coding systems designed for health practitioners should not be used for
patients. At present, not many instruments focus on both parties (Braddock et al.,
1999 [52]). To obtain a comprehensive evaluation of SDM, instruments and
coding systems that analyze both doctor and patient behaviors need to be
combined.
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2.3 Current Status of SDM
2.3.1 Models of Decision Making in Medical Care Context
In studying the patient’s role in medical decision making, especially in
handling the conflict between autonomy and health, between the values of the
patient and the values of the physician, different models of making healthcare
decisions have been proposed. Elwyn et al (Elwyn et al., 1999 [53]) has modeled
the clinical decision-making as a spectrum from a paternalistic model at one end
to the informed choice model at the other end (Charles et al., 1997[54]). In the
middle of this spectrum lies the model of shared decision-making (Figure 2-1).
Paternalistic

Shared Decision-Making

Informed Choice

Figure 2-1: Spectrum of Patient Clinician Interaction
The paternalistic model is also known as the parental or priestly model.
This model obliges patients to seek ‘expert’ help and to comply with the medical
regimen. It is a model where physicians do what is thought best for patients
without necessarily eliciting the latter’s input. The ‘informed choice’ decisionmaking model stands on the opposite end of the spectrum. This model, also
known as the ‘consumer model’, describes a process whereby patients receive
information from their physicians about treatment choices but they will make the
final decisions on the treatment. Under this model, a patient’s values will be well
defined and appreciated. It is the physician’s obligation to provide the patient with
all medical information relevant to the disease and available interventions. The
patient then has both the information required and the personal preferences
necessary for decision-making. One concern about the ‘informed choice’ model
is the possible high anxiety level the patient may feel due to the sole responsibility
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in decision making (Quill and Brody, 1996 [55]). In the extreme case, they may
feel being abandoned by the doctor. While vastly different, neither the
paternalistic model nor the informed choice model involves both physician and
patient simultaneously in the clinical decision making process, giving room to a
more compromised model.
The shared decision making model, by definition, represents a process in
which physicians and patients share decision making. This model has attracted
more and more attention and been advocated as the ideal model for physicianpatient interaction. In addition to ethical reasons that have prompted the use of
SDM, there is also growing evidence that this is the approach most patients desire
for.
Research has shown that when patients take a more active part in making
decisions about their care, treatment outcomes turn out to be better. One example
is the achievement of improved diabetic control in studies by Greenfield, Kaplan
and Brody (Greenfield et al., 1988[56]; Kaplan et al., 1989[57], Brody et al.,
1984[58]). Recent work also reveals the complexity that underlies the apparent
relationship between patient involvement and improved health outcomes. Street
and Voigt (Street and Voigt, 1997[59]) demonstrates that the patient’s perception
of decision control is a key issue with both stable and dynamic characteristics,
depending on the patient’s personality, their involvement within the consultation,
and the eventual health outcome. Huygen et al (Huygen et al., 1992[60]) shows
that certain types of consulting styles could improve the health of patients across a
practice list. There will also be times when patient preferences will be in direct
conflict with clinical guidelines. One classical example is the wish to receive
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antibiotics for viral illnesses. These conflicts may threaten doctor–patient
relationship (Bradley, 1992 [61]) and health outcomes (Little et al., 1997 [62]).
Shared decision-making will need to accommodate such contradictory beliefs.
Stewart (Stewart et al., 1997[63]) reported that where patients ‘perceived’ that
they had achieved ‘common grounds’ with physicians, there were fewer demands
on laboratory and referral services. To sum up, potential positive outcomes from
the shared decision model are the provision of clear information, input from
patients, shared information and shared decisions, agreement between the patient
and the doctor on problems and the treatment plan, and finally, a positive and
reliable relationship between the patient and physician.
2.3.2 Characteristics of Shared Decision Making (SDM)
The essence of a shared decision making includes two broadly defined
aspects: sharing information and sharing decision. Sharing information and
sharing decisions are not synonymous (Ong et al., 1995 [64]).They have separate
goals and require different skills. Shared decision-making will not happen unless
preceded by the sharing of information. Charles et al (Charles et al., 1997[12])
summarized the four characteristics of shared decision making process as follows.
First, shared decision-making involves at least two participants — the doctor and
the patient — and often many more, such as patient family or professional
colleagues. Second, both parties take steps to participate in the process of
treatment decision-making. Third, information sharing is a prerequisite to shared
decision making. Fourth, a treatment decision is made and both parties agree to
the decision.

19
In the shared decision making model, information sharing is of utmost
importance. It requires an open two-way exchange of information and opinions
about probabilistic data so that medical decisions will be made based on a better
understanding of options and outcomes. This process cannot occur within a
doctor-centered consultation. Instead, consultation has to be patient-centered
(Stewart et al., 1995 [63]). Such a consultation is also known as ‘risk
communication’ for the fact that the patient is given information with unknown
impact. The information can affect the patient’s decision either positively or
negatively. In that sense, while doctors are increasingly aware of the need to
inform patients about treatment options and encourage patients to be more
involved, they should also disclose the benefits and risks associated with each
treatment. At the same time, individual choice can be sensitive and involve value
judgments. Same treatment effect may be interpreted as trivial by some patients
but as significant by others.
Sharing information based on patients’ needs can reduce the risk or
negative impact and maximize the benefits of patient-centered medical care. For
example, as mentioned above, a sizeable minority of cancer patients prefer to
relinquish decisional control, particularly if faced with a dire prognosis.
Advocating active patient involvement for those patients would endanger, rather
than engender, patient autonomy. Given the current emphasis on patient
participation, understanding patient preferences can determine what kind of
information to share, how much information to share, and to what degree the
information should be shared.
2.3.3 Strategies of Shared Decision Making (SDM)
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As SDM requires a commitment from both patients and physicians,
strategies for the advancement of SDM have either focused on patients,
physicians, or both. For patients, the use of patient decision aids (PDAs) is a wellacknowledged and increasingly popular means to prepare for SDM. For
physicians, SDM training programs are offered to improve SDM skills. The
training programs along with PDAs have greatly facilitated SDM in medical
consultations.
For physicians, research (Loh et al., 2007 [69]) has found that the SDM
training is attractive to a broad range of physicians and most physicians displays
a positive attitude towards it. Most SDM trainings orientate around a set of SDM
core competencies, defined in the framework for SDM (Brody et al., 1989[66];
Street and Viugt, 1997[34]). These competencies exceed the basic communication
skills in that advanced skills are required for partnership-building, risk
presentation, discussion of evidence-based information, and explicit dialogue.
The effectiveness of SDM training was evaluated in Elwyn et al.(Elwyn et
al., 2004[67]). The clinicians in that study demonstrated greater involvement of
patients in treatment decision making after participating in skill development
workshops. It appears that the most effective way to increase clinicians’ abilities
to involve patients is to familiarize them with detailed information before
discussing skill development techniques. After the workshop, the clinicians were
able to integrate the risk communication aids by using the graphical illustrations
in scheduled review consultations with real patients after the training intervention.
As part of a national German research consortium called ‘‘Patients as Partners in
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the Medical Decision Making Process,’’ (Loh et al., 2007[68]), a clinical trial was
conducted to explore the possibility of implementing SDM training for physicians
in practice. Results suggest that for the SDM training be attractive to a broad
range of physicians. Overall, physicians from 13 specialties signed up for the
training. Higher interest was observed in the more “people-oriented’’ specialties,
such as family medicine, probably due to the fact that physicians in those fields
tend to value the physician–patient relationship more than their counterparts in
more ‘‘technology-oriented’’ specialties. Approximately 94% of the participants
in that sample showed a positive attitude towards SDM. This result is consistent
with other studies showing SDM is the most well respected interaction model
among physicians (Murray et al., 2007 [69]; Charles et al., 2004[70]).
Although most physicians view SDM favorably, the actual use of SDM
lags far behind the ideal implementation level. As a result, many patients do not
feel involved to the desired extent. It seems that though physicians are motivated
and like the idea of SDM, they are not well prepared to implement it yet. When
physicians choose to adopt a SDM model, they are faced with the challenge of
providing patients with information and making shared decisions with them. All
these require advanced SDM communication skills that may not be present yet.
This suggests that more efforts should be put into disseminating SDM training
and new tools should be developed so that information like risks and benefits can
be shared more easily.
As a patient-centered model, shared decision-making has the potential to
improve patients understanding and satisfaction, patient adherence, and a
reduction in the use of resources such as laboratory services and referral.
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However, with more patient’s involvement comes new responsibilities, such as
evaluating risks and benefits of each treatment. Patient Decision Aid or PDAs
have been introduced to help patients analyze such risks and benefits. The interest
in PDAs has been rising. The next section will be devoted to the review of the
utility of PDAs in SDM.
2.4 Decision Aids
2.4.1 Concept of Decision Aids
Decision aids commonly refer to tools that are designed for patients or
people facing healthcare decisions. They aim to help people deliberate,
independently or in collaboration with others, about options. This is usually done
by considering relevant attributes in forecasting short, intermediate, and long-term
outcomes and consequences. Healthcare providers may also use decision aids as
adjuncts to prepare patients for decision making. Decision aids usually provide
descriptive information on the disease or condition, probabilities of outcomes
tailored to a person’s health risk factors, an explicit clarification of values
exercise, information on others’ opinions, and guidance in the steps of decision
making and communicating with others. Decision aids may be administered with
the use of various media, such as brochures, videotapes, decision boards,
interactive videodiscs, interactive computer programs, audiotapes, audio-guided
workbooks, pamphlets, and group presentations. Excluded from the definition of
decision aids are passive informed consent materials, educational interventions
that are not geared to a specific decision, and interventions designed to promote
compliance with a recommended option rather than a choice based on personal
values.
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2.4.2 Types of Decision Aids
Although all decision aids provide information on the benefits and risks of
treatment options, the difference lies in how the information is presented. Some
are interactive and others are non-interactive. Interactive decision aids use
interactive multimedia programs such as videodisks, computer programs, and
personal interviews. Non-interactive decision aids use more traditional media,
such as decision boards, videos, brochures, posters, pamphlets, written vignettes,
written materials, and checklists, prompt lists, other consultation session based,
scripted counseling, and audio-guided workbook.
2.4.3 Utility of Decision Aids
Decision aids aim to provide accurate, balanced, and tailored information
to help patients improve their knowledge and skills in shared decision making.
For example, using the probability of different treatment outcomes computed by a
decision aid, patients can form a more realistic expectation of treatments (Tversky
and Kahneman, 1981[71]). They can express their thoughts in the terms familiar
to physicians (Fischhoff et al., 1980[72]). With functions which provide by
decision aid, they will help patients handle the uncertainty in choosing treatment
options with more confidence (O’Connor, 1995 [73]). Decision aids offer one of
the most effective means to ensure that patients are informed about their treatment
options. These aids can come in the form of a brochure, video, interactive
website, or a combination, and they provide balanced, evidence-based information
about medical conditions, the patient’s treatment options and the tradeoffs
involved in each option. High-quality decision aids can help patients understand
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their various options and the potential outcomes within the context of their own
preferences and values.
2.4.4 Efficacy of Decision Aids
Considerable research has been devoted to studying the efficacy of
decision aids. Overall, results have been positive. Decision aids have the potential
to increase the likelihood that choices are based on better knowledge, realistic
expectations of outcomes, and personal values for cancer patients. Annette et al
(Annette et al., 1999[74]) reviewed published evidence on the efficacy of decision
aids on cancer treatment outcomes. They summarized the evaluative studies from
the annotated bibliography (O’Connor et al., 1999[75]) by searching databases
like MEDLINE®, CINAHL®, PsycINFO®, and Current Contents®. They also
manually searched Medical Decision Making and Health Expectations. Three
types of studies were included. The first type was before/after studies that
evaluated decision aids with patients at the point of decision making. The second
type was randomized trials that evaluated decision aids in comparison to “usual
care” with patients at the point of decision making. The third type was
randomized experiments comparing different methods of decision support in
decision aids either with patients at the point of decision making or with
volunteers making hypothetical choices. Their research results indicate that
cancer-related decision aids are acceptable to patients and especially helpful to
those who are uncertain in making decisions.
Stacey el al (Stacey et al., 2008[76]) conducted randomized trials of
cancer patient decision aids. They conclude that patients exposed to decision aids
are more likely to make higher-quality decisions. Randomized trials of patient
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decision aids were also studied in Annette and O’Connor(Annette and O’Connor,
2007 [77]).Their findings include that decision aids can increase knowledge,
lower decisional conflict, and encourage more active patient participation in
decision making. However, decision aids have impact on patient anxiety and
satisfaction level during the decision making process.
2.4.5 Implementation of Decision Aids
The implementation of decision aids is based on decision theories from
economics and cognitive psychology (Stacey et al., 1997[76]; Annette et al.,
2007[77]; Keeney et al., 1976[78]). These theories describe decision making by
options, outcomes, and probabilities of outcomes so that patients can make value
judgment on the benefits versus the risks. Many decision making frameworks
broaden this cognitive perspective by including emotional, social, and
environmental dimensions (Tversky et al., 1981[79]; Fischhoff et al., [80]; Janis
et al., 1977[81]; Orem, 1995[82]; Norbeck, 1988[83]). For example, the Ottawa
Framework (O’Connor et al., 1998[84]) identifies several determinants of health
care decisions that may be modifiable by decision aids. The goal is that the
decisions made are more likely to be: 1) informed (i.e., based on better knowledge
and realistic expectations), 2) consistent with personal values, and 3) actually
implemented. In clinical practice, successful implementation of patient decision
aids requires access to the interventions, practitioners’ awareness and skills in
using those interventions, and environmental structures that support their use
(Graham and Logan, 2004 [85]).
The Cochrane Inventory of Patient Decision Aids has over 500 decision
aids. Out of this huge inventory, about 200 are currently available (Stacey et al.,
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2008 [86]).These aids come from both academic institutions and health
information organizations. Examples of the cancer-related aids are available from
the Foundation for Informed Medical Decision Making (www.fimdm.org),
Healthwise (www.healthwise.org), the Mayo Clinic(www.mayoclinic.org), and
the Ottawa Health Research Institute (www.ohri.ca/decisionaid) which also
provides a personal decision guide and an interactive tool to explore different
decisions.
Given the variable quality of the available patient decision aids, a group of
experts from 14 countries established a consensus on a set of criteria for judging
their quality (Elwyn et al., 2006[87]). These criteria are categorized into the
domains of essential content, development process, and evaluation. The
International Patient Decision Aid Standards (IPDAS) is available as a checklist
(www.ipdas.ohri.ca) and is currently being used to rate the quality of patient
decision aids that are publicly accessible. These quality ratings are available at
www.ohri.ca/decisionaid(see Decision Aid Library Inventory). The IPDAS
checklist was designed to be used by developers, patients, health care
professionals, health care insurers, administrators, policy makers, and researchers
to critically appraise individual decision aids or to compare across available
decision aids on the same topic.
Patients can access most current decision aids directly on the Internet or
through the help from health care professionals or disease-specific community
resource programs (O’Connor,Wennberg and Légaré, 2007 [88]). For example,
several cancer programs have integrated decision aids and decision quality
measures within the process of care for women with breast cancer considering
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treatment options (Silvia and Sepucha, 2006 [89]; Kearing et al., 2006[90]). In
primary care, cancer screening decision aids have also been incorporated into
routine medical visits (Brackett et al., 2007[91], Brooks et al., 2006[92]).
Access to Decision Aids can have substantial impact on patient decisions.
(Kennedy et al., 2002[93]). A systematic review of more than 80 randomized
controlled trials found wide differences between the choices made by patients
facing elective decisions who had access to decision aids versus patients who
received usual care – who were informed by their providers.(Stacey et al.,
2011[94]). Compared with patients who got usual care, patients who had access
to a decision aid were better informed about their treatment options; more
satisfied with their decision; experienced less discomfort, greater reduction of
symptoms and more improvement in general medical conditions; had less conflict
about the decision once they made it; and were 20% less likely, on average, to
choose the more invasive option. There was no difference in outcomes among the
groups.
As stated above, access to decision aids tool should be considered when
we build decision aids tool for patient. Considering this, a web-based internet site
which allow patient to access from their home or clinic at any time will be
developed as a decision aid format. This computer program will be implemented
as a decision support system for patients. More details on the decision support
system are given in Section 2.5.
2.5 Decision Support System
2.5.1 Concept of Decision Support System (DSS)
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A decision support system aims to support making business or personal
decisions. Technically speaking, a decision support system (DSS) is an interactive
knowledge-based, software information system. Such a system compiles the
information from multiple sources, such as raw data, documents, guidelines, and
scientific models, in solving problems and making decisions.
2.5.2 Type of Decision Support System
No universally-accepted taxonomy has been established for DSS.
Depending on whether the system uses knowledge or not, DSS can be roughly
classified as knowledge-based or non-knowledge-based. From the user’s
perspective, DSS can be labeled as passive, active, or cooperative. A passive DSS
is a system that aids the process of decision making, but does not bring out
explicit decision suggestions or solutions. A cooperative DSS uses an iterative
process between system suggestions and user modification. After the system
provides decision suggestions, the decision maker can modify, complete, or refine
them and the system will use the new input to generate new suggestions. This
process iterates until a consolidated solution is reached. Using the mode of
assistance as the criterion, Power (Power, 2002 [95]) differentiated DSS systems
as being communication-driven, data-driven, document-driven, knowledgedriven, and model-driven. In short, a communication-driven DSS supports more
than one person working on a shared task. A data-driven DSS or data-oriented
DSS emphasizes access to and manipulation of a time series of data. A documentdriven DSS manages, retrieves, and manipulates unstructured information in a
variety of electronic formats. A knowledge-driven DSS provides specialized
problem-solving expertise stored as facts, rules, procedures, or in similar
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structures. Finally, a model-driven DSS emphasizes access to and manipulation of
a statistical, financial, optimization, or simulation model.
2.5.3 Decision Support System in Healthcare Domain
Based on decision support theory, a DSS can be built in almost any
knowledge domain. The healthcare domain has witnessed quite a growth in DSS
applications, concepts, principles, and techniques. One DSS system is the Clinical
Decision Support System (CDSS), which has been defined as "Clinical Decision
Support Systems link health observations with health knowledge to influence
health choices by clinicians for improved health care" by Dr. Robert Hayward of
the Centre for Health Evidence. This definition underscores two important
features of CDSS. First, CDSS is knowledge-based. Second, it is functional.
CDSS incorporates interactive computer programs to achieve the function of
assisting physicians and other health professionals with their decision making
tasks.
CDSS can provide support to decision making at various stages in the
healthcare process from preventive care through diagnosis and treatment to
monitoring and follow-up. In a clinical setting, different decision support systems
have been developed for different stages. The most common use of CDSS at
present is to meet clinical needs of achieving accurate diagnoses. Such CDSSs
aim at the diagnostic tasks in the care process, hence known as Diagnostic
Decision Support System (DDSS). Examples of DDSS systems are DXplain,
Iliad, Meditel, QMR (The book ‘Clinical Decision Support System: Theory and
Practice’ which was written by Et S. Berner, chapter 5). The performance of these
systems was evaluated in Berner et al. (Berner et al., 1999 [96]).
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Another popular use of CDSS is to provide physicians and pharmacies
with convenient prescription ordering systems. These systems bear different
names like Clinical Physician Order Entry, Computerized Physician Order Entry
or Computerized Prescriber Order Entry, all abbreviated as CPOE. In essence,
COPE is a process of electronic entry of medical practitioner instructions for the
treatment of patients (particularly hospitalized patients). These instructions are
communicated over a computer network to relevant constituents of the healthcare,
including hospital staff, pharmacy, laboratory and radiology, which are
responsible for fulfilling the order. Using a computerized system decreases delays
in order completion, reduces clerical errors such as those due to handwriting in
transcription, allows order entry at the point-of-care or off-site, provides errorchecking for duplicate or incorrect dosages or tests, and simplifies inventory and
posting of charges. Statistics have shown that CPOE are able to reduce the general
medication error rate by 80% and errors with serious potential patient harm by
55% (Colpaert et al., 2006[97]). Other studies have also suggested extra benefits
of CPOE, such as automatic dosage alerts (e.g., letting the user know that the
dosage is too high and thus dangerous) and interaction checking (e.g., telling the
user that two medications taken together could cause health problems).
CDSS can also be tailored for particular conditions or types of patients.
Such a system will have access to guidelines and other external databases so that
it can provide specific information to those patients. It can also be programmed to
send reminders for preventive care and alerts about potentially dangerous
situations.
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To sum up, CDSS can lower cost, improve efficiency, and reduce
inconveniences. In ideal cases, CDSS can address these three issues
simultaneously. One such example is alerting clinicians to potentially duplicative
testing. For routine tasks, such as presentation of a predefined order set, CDSS
can relieve the clinician from the burden of reconstructing orders for each
encounter. For more complex tasks, such as diagnostic decision making, the aim
of CDSS is to assist, rather than to replace, the clinician. In that case, CDSS will
offer suggestions and the clinician will filter the information, review the
suggestions, and then decide what action to take.
2.5.4 Gap in Decision Support System for Patient
Despite the wide range of clinical decision support systems that have been
implemented by institutions and pharmaceutical companies, no such decision
support system has been developed with patients as primary users. In other words,
patients have been treated as passive receivers of medical decisions. Based on our
large-scale review as discussed in introduction section of this writing, no CDSS is
available for patients yet. Actually, even the definition of CDSS suggests that
their target users are clinicians and physicians, not patients. There are systems that
can help patients keep track of their personal health records, such as Microsoft
Vault and Google Health. However, they are more in line of a data repository with
no decision support functionality. As primary stakeholders of medical decisions,
patients have yet to be given adequate consideration in the CDSS system
development.
This huge gap is the main motivation for us to conduct this study. The
main goal of this research is to develop a DSS that is patient-oriented rather
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clinician-oriented. This DSS aims to provide patients and their family with
important and specific information on the disease (e.g. lung cancer). With the help
of this system, patients will be able to play a more active role in the shared
decision making process.
2.6 Patient-Oriented Evidence-Based Decision Making
Modern medical care has been influenced by two paradigms: patientcentered medicine and evidence-based medicine. These two paradigms have
gained momentum rather rapidly. Today, both of them play an important role in
daily clinical decision making. Patient-centered medicine puts a strong focus on
patient participation by taking into account the patients’ perspective in tuning
medical care to the patients’ needs and preferences. The uniqueness of each
patient, such as individual needs, preferences, and emotional status, are
emphasized as relevant factors in decision-making. Evidence-based medicine, on
the other hand, focuses on offering the best available evidences about the most
adequate treatment. These two paradigms are highly relevant, but yet seem to
have operated separately. One challenge is how to bring them together. Actually,
both paradigms can benefit from interchanging ideas and principles with each
other. The primary goal of TreatQuest® is to integrate these two paradigms in a
seamless manner. Patient involvement and evidences for treatment options will be
combined, which is the main motivation for the concept of patient-oriented
evidence-based decision making.
The most important feature of a patient-oriented approach is that it
provides information that matters to patients. Patients need the help of a decision
support system that actually understands their needs and is able to provide the
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tailored and customized information by screening out irrelevant information. A
patient-oriented decision support system must meet the following two basic
criteria: the system must be able to address possible questions that patients
encounter and the system must have the power to help them make decision.
Patient-oriented decision support systems aim to help patients generate insights
into the decision process. They achieve this goal by educating patients about the
options and outcomes for the disease, assessing their preferences for the outcomes
and revealing the implications of treatment options. Throughout this process, the
system can also help patients understand how other patients had been treated and
what outcome they have received (Scott et al., 1999 [98]).
The term ‘evidence-based medicine’ (EBM) is relatively new but its origin
can be traced back to ancient Greek and Chinese medicine. The history of EBM
can be roughly divided into four eras: ancient (before the 17th century),
renaissance (from the 17th to the 19th century), transitional (1900-1970’s), and
modern (after 1970’s) (Claridge & Fabian, 2005[115]). The ancient era consists of
historical and anecdotal accounts of what may be loosely termed as EBM. In the
renaissance era, one important figure of EBM is Thomas Beddoes, who was a
reforming practitioner, a teacher of medicine, and an associate of leading
scientific figures. In the book called “A Letter to the Right Honourable Sir Joseph
Banks, Bart. P. R. S.: On the Causes and Removal of the Prevailing Discontents,
Imperfections, and Abuses in Medicine” that he coauthored with Joseph Bank, he
proposed to cite scientific objections (Beddoes & Banks, 1808[116]).
It is during the transitional era of EBM that a model of ecology of medical
care was proposed by White and colleagues in 1961 (White et al., 1961[117]).
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This model shows a valid perspective of medical care use in the 1960s. It
organizes the complex relationships known to affect health care and the health of
populations and states their implications for the organization of health care,
medical training, and research. The model has also stated geo-demographic and
socioeconomic status as factors influencing health care use. Despite substantial
changes in medicinal care in recent years, such as the improved techniques for
data collection, a reassessment of health care use by the ecology model has
actually shown similar structures to those in the 1960s.
In the modern era of EBM, the term “evidence based” was first used by
David Eddy in 1990 and the term “evidence-based medicine’ first appeared in the
medical literature in 1992 in a paper by Guyatt and colleagues(Guyatt et al.,
1992[124]). The methodologies used to determine “best evidence” was first
established by a research group at McMaster University led by David Sackett and
Gordon Guyatt(Sackett et al., 1993[125]; Sackett et al.,1994[126]). Sackett
actually defined EBM as “the integration of best research evidence with clinical
expertise and patient values” (Sackett et al., 1996[119]).
Along with the growth of evidence-based medicine, more attention has
been paid to patients’ expectation and request from healthcare services (Kravitz,
2001[120]). For example, a classification system, TORP, was set up to understand
the links between patients’ unarticulated desires and expectations, patients’ verbal
requests, physicians’ provision of health care services, and patients’ and
physicians’ perceptions of the visit (Kravitz, Bell & Franz, 1999[121]). The
TORP system features 11 categories of requests for patient information and 8
categories of requests for physician action. Using the TORP system helps
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researchers and healthcare providers identify the most common forms of patient
requests as well as the most successful clinical negotiations to meet those needs.
As another example, Mayor (Mayor, 2004[122]) illustrates the process and
components of a decision for patient in the evidence-based medicine setting, as in
Figure 2-2. The figure clearly shows how to make decisions based on the best
current evidence while taking into account the knowledge about the particular
patient or services under consideration.

Figure 2-2 Patient Decision Making Process in Evidence-Based Medicine
As an information-rich enterprise, EBM has been radically transformed by
technology advances. A greater and more seamless flow of information within a
digital health care infrastructure can be delivered and compensated by
incorporating electronic health records (EHRs) /electronic medical records
(EMRs), which also opens up the possibility of developing better clinical decision
support system and of providing cost-effective treatments for patients. For
example, the Intermountain Project designed by Intermountain Healthcare, Inc.
was able to offers high-quality care while reducing costs through using
technology to heavily computerize the healthcare services (November,
2011[123]).
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Evidence-based decision making is another equivalent important aspect of
the patient-oriented evidence-based decision making concept. It involves the
explicit, conscientious, and judicious consideration of the best available evidences
in making health care decisions (Alejandro, 2000[99]). Evidence-based decision
making is supported by a rapidly evolving set of methods and tools. Applications
that support the consumer’s role in decision making has become a strong focus in
the United States (Clancy, 2005 [100]). Consumers are looking for high-quality
evidences to answer their questions. Those evidences offer them scientific
information to make correct decisions. Hence, whether a patient can make
evidence-based decisions relies on whether the patient has access to evidencebased information. An evidence-based decision support system can make such
information extremely handy by providing patients with access to up-to-date and
valid knowledge at the right time, at the right place, in the right amount, and in
the right format (Eysenbach, 2001 [101]). Moreover, this service will be delivered
in a low cost, fast, and effective manner.
The TreatQuest® system intends to provide an evidence-based platform
that is built with many kinds of knowledge resources. Mainly, three types of
evidences will be included: similar case analytical results based on the SEER
data, clinical practice guidelines, and scientific papers published in peer-reviewed
journals. Using these evidences, patients will become more educated about
treatment options. They can also discuss with physicians on what the guideline
currently offers, what clinical research have shown, and what the SEER data have
found. This way, patients will receive the strong support at the time of decision
making. As the information gap between patients and clinicians have been greatly
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narrowed, patients can be more engaged and informed in the treatment decision
making process. By bridging the patient-centered medicine with the evidence-based
medicine, the TreatQuest® system aims to improve the overall quality of
healthcare.
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Chapter 3 Methodology
This dissertation study employs both quantitative and qualitative research
methods. Section 3.1 describes the overall research design, including the stages
and the methods. Section 3.2 describes the data structure of the TreatQuest®. The
detailed design of TreatQuest® is given in Section 3.3.
3.1 Research Design
In order to design a practical, accountable, and effective decision
support system for patients, the system development life cycle (SDLC) model
will be implemented. In software engineering, the SDLC concept underpins
many software development methodologies. These methodologies form the
framework for building the patient information system for this study. The
SDLC model can be divided into five phases. As illustrated in Figure 3-1,
these phases are analysis, design, implementation, testing, and evaluation. In
applying this framework to our study, the first step is to analyze the needs of
patients so that the functions of TreatQuest® can be defined. Based on those
functions, the architecture of TreatQuest® is then designed. This covers all the
desired features of TreatQuest®, such as system diagram, data model, process
chart, and personalization logic. In the implementation phase, software code is
written and the whole system will be built. It is at this stage that the design of
TreatQuest® is actually translated into a complete web-based system. Finally,
in the testing phase, functional testing, evaluation, and validation activities
will be conducted to examine how patient actually use or like the system.
Their feedback will also be used iteratively to further improve the system.
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Figure 3-1 Model of the Systems Development Life Cycle
3.2 Data Source
Cancer data may be collected by Health Management Origination (HMO),
government, and no-profit organizations. All these data sources can be used in
TreatQuest®. They are referred as external data to differentiate from the data
collected by TreatQuest®. There are two options to use the external data. One is
to access those data by using web services or specific software offered by data
providers, the so-called on-demand access. One drawback of this option is that
data access will be restricted by a third-party service, such as the web services or
software functions. A better option seems to store the external data in the
TreatQuest® system so that it is always available. This requires first to gain the
license to use the data as well as to load the data properly into the repository. This
option gives TreatQuest® more freedom in conducting queries. Once we have a
copy of those external data, it is more flexible to retrieve and gather information
based on the needs. The disadvantage of this option is we have to load the data
into our repository first. But once the data is loaded, we can query and
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manipulate the data easily, so useful information can be generated based on our
needs.
In TreatQuest®, the second option was adopted. Figure 3-2 illustrates the
internal data repository of TreatQuest®. At the top of the chart is the data source,
which includes the possible external data as listed in the external static data
source box. TreatQuest® makes a copy of these data and stores them in the
repository. In addition to the external data, the TreatQuest® internal repository
also features research literature, guidelines, and patient data collected by
TreatQuest®, referred as internal data in the figure. The internal data consist of
both user information and patient information. User information includes user
name, password, email, and security related information. Patient information
includes demographic information, diagnose information, staging information,
and histology information, which can be used to build dynamic queries to retrieve
treatment-related information. With all these data, TreatQuest® internal
processing engine can easily retrieve relevant data and information from the
internal repository in generating dynamic query results to users. For example,
using the collected patient information and the SEER data, similar cases can be
retrieved and analyzed for a user.
Moreover, TreatQuest® can retrieve data and information that resides
outside of TreatQuest®. Those data are referred as external data repository at the
bottom of Figure 3-2. By adapting Google customized search function,
TreatQuest® external processing engine can gather information and display them
in TreatQuest® without going to those external websites. This way, users can
easily retrieve information from external websites, such as WebMD. In addition
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to the search function, links to those data are also provided. Figure 3-2 also shows
how TreatQuest® uses internal data repository. By combining the information
from the internal and external sources, TreatQuest® provides hybrid information
to the end users, who can then use various criteria in conducting dynamic queries.
In this sense, TreatQuest® could be viewed as hybrid, dynamic data, information
and knowledge resources for patients.

Figure 3-2

TreatQuest® Data/Information Organization
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3.2.1 SEER Data
The Surveillance, Epidemiology, and End Results (SEER) program is
offered by National Cancer Institute (NCI), which has collected and published
cancer incidence, prevalence, and survival data from population-based cancer
registries since 1973. SEER data is unique in that it covers approximately 26
percent of the U.S. population. The SEER registries routinely collect data on
patient demographics, primary tumor site, tumor morphology, stage at diagnosis,
and first course of treatment, and they follow up with patients for vital status.
Moreover, the SEER Program is the only comprehensive source of populationbased information in the United States that actually collects information on the
stage of cancer at the time of diagnosis. It also provides patient survival data for
the analysis of longitudinal trends. By using SEER data, it is possible to provide
population level cancer related case match for site and stage of disease.
SEER data consist of 124 data items. A detailed description of all items is
given in the Appendix A. The original SEER data file is in the text format. In
order to use such a large SEER dataset in TreatQuest®, both data load and data
preprocessing process were implemented. The data load process reads a SEER file
and inserts it into a temporary database table. The data preprocessing inserts the
necessary data items from the temporary database table to the TreatQuest® tables.
By these two steps, SEER data will be used more effectively and efficiently in
TreatQuest®.
3.2.2 Data Load
SEER data comes with a structured directory in the ASCII text format.
Based on different cancer sites, data from different SEER registries are stored in
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different data files. Figure 3-3 is an example of the directory structure and files of
respiratory cancer data from different SEER registries. To use these SEER data as
internal repository, they have to be imported into the TreatQuest® system.

Figure 3-3 Example of SEER Data Directory Structure
To load the SEER ASCII text format data file, a SSIS package has been
developed. The control flow of this SSIS package is shown in Figure 3-4. By
running this SSIS package, all related information from SEER data sources can be
loaded and stored as tables.
Following that, a database named SEER_Data_Load was created, which
will serve as the host of SEER data and information. In essence, this loading
process converts the original SEER data elements into the database columns in the
TreatQuest® database tables so that patient cases will be represented in a
consistent manner. This practice enables the query of similar patient cases, which
is a crucial component of our system. The original SEER data file has information
on patients diagnosed from 1973 to 2008 and lung cancer research data are stored
in the filed named RESPIR.TXT in each sub-directory. Using the SSIS package,
all the lung cancer related data from year 1973-2008 have been loaded into the
SEER_Data_Load database.
3.2.3 Data Preprocessing
Data preprocessing is an important step in data mining and data analysis.
Examples of data pre-processing functions are cleaning, normalization,
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Figure 3-4 Control Flow of SEER Data Load
transformation, and selection. As described above, the data loaded into
SEER_Data_Load database are loosely controlled, thus additional data
preparation and filtering steps are necessary to remove noisy, redundant, or
unreliable data.
Not all 124 data items in the SEER data were collected for all years. For
example, the data item of RX Summary - Surgery Primary Site is only available
after year 1998. Another example is that data item RX Summary – Surgery Type
was collected from 1973 to 1997 only. More importantly, new items were added
after 2004, especially those items such as tumor size, lymph node, and metastasis
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required for derived AJCC (American Joint Committee on Cancer) staging
information. As these items bear significant importance in developing a patient
support system, this study used the SEER data after 2004 only.
Based on the clinical domain, data items that are essential for representing
a patient’s ontology information are identified. Those items can be categorized as
demographic information, diagnosis information, treatment related information
(e.g., surgery and radiation), and survival information. To represent and store
them more efficiently, data items are grouped into different database tables with
each item being a table column.
To complete the data preprocessing, a series of stored procedures were
developed and implemented, as shown in Figure 3-5. These procedures import the
filtered and converted data from SEER_Data_Load database to the final
destination in the TreatQuest® database.

Figure 3-5 Example of Stored Procedure for Data Preprocessing
Tables with patient information are: Patient_Demographic,
Patient_Diagnosis, Patient_Surgery, Patient_RadiationTherapy, and
Patient_Survival. Figure 3-6 is a screenshot of those tables.
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Figure 3-6 Tables in TreatQuest® after Data Preprocessing
3.3 TreatQuest® System Design
System design is a process of defining the architecture, components,
modules, interfaces, data model, and process flow for a system to satisfy specified
needs. It can also be viewed as the effort to develop an application from a
theoretical model. This section will describe the technical details of TreatQuest®.
Topics covered are selection of the structural elements and their interfaces,
behaviors as specified in collaboration among those elements, composition of
structural and behavioral elements, functionality, usability, and special features
incorporated into the system.
3.3.1 Architecture of TreatQuest®
TreatQuest®is designed as a web application by using tools like Microsoft
ASP.Net, Microsoft Internet Information Server, Microsoft Windows Server and
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Microsoft SQL Server. It works in web browser such as Microsoft Internet
Explorer. Figure 3-7 shows the logical architecture of TreatQuest®.

Figure 3-7 Architecture of TreatQuest®
Microsoft SQL Server is the software used as database management
system. Raw data, processed data, and information and knowledge are stored in
the corresponding databases of SQL Server. Query processing is divided into
internal and external processing. The internal processing engine retrieves the
query results from internal data repository and the external engine handles queries
to external data sources. Both internal and external results are combined in the
results and returned to the user simultaneously. The IIS Web Server is used to
process requests submitted from the user’s browser. For external information and
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knowledge query, web service technology was adapted to retrieve external
information.
3.3.2 Process Flow of TreatQuest®
This section describes how TreatQuest® system typically processes an
inquiry using the illustration in figure 3-8. Suppose a user is interested in
obtaining the treatment information of all the cases that are similar to his or her
case, or the so-called similar case query. When TreatQuest® server receives such
a request, it will send the request to the TreatQuest® processing engine. The
engine translates the query to a corresponding data query and a knowledge query
and retrieves the result from the TreatQuest® internal data repository. Direct
answers will be generated by the SQL query. More sophisticated answers will
trigger more steps in data processing, data mining, and knowledge acquisition.

Figure 3-8 Process Flow of TreatQuest®
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Meanwhile, TreatQuest® external processing engine will send a web service call
to the external web service server. Results from the internal and external engines
will be combined and returned to the user.
3.3.3 Personalization and Tracking Patient Profile
In order to keep track of the profile of a patient, different tables were
created in the TreatQuest® database. At the frontend, users can submit their
information via web based user interface. At backend, the information will be
stored into the database. TreatQuest® stores user preferences by asking such
information at registration and saving it in cookies. When a returning user is
detected, the system will invoke the profile to personalize the use of the system.
The personalization and tracking process is illustrated in Figure 3-9.
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Figure 3-9 Personalization and Tracking Process in TreatQuest®
3.3.4 Data Model of TreatQuest®
The backend of TreatQuest® consists of databases that store data,
information, and knowledge. These databases consist of multiple layers. In other
words, several layers of data and information are either stored in one database or
distributed among multiple databases. The lowest layer stores the original
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information while the higher layers stores more general information extracted
from the lower layers. For example, the SEER_Data_Load database described in
section 3.2.3 is at the lowest layer with only the original data.
Data in TreatQuest® are classified as primitive and high-level data. The
former is actual data and the latter resides at the higher levels of the concept
hierarchy. Correspondingly, a primitive-level query is a query whose constants
involve primitive data only, whereas a high-level query is a query whose
constants involve high-level data. To retrieve results at different levels, a query
can be defined either at the primitive or high level. Both primitive data and highlevel data can be aggregated or summarized according to different queries.
TreatQuest® is implemented as a web portal that provides services to its
users. At the minimum, new visitors should be able to create an account and
returning visitors should be able to log in. Most of pages or services are available
only to the logged in users and as described above, information is personalized in
some pages. For example, patients diagnosed with stage I lung cancer will see the
Treatment Wizard for Stage I cancer only. Likewise, only treatment option for
stage I will be offered to these patients. That is also to say, they will have
customized access to treatment wizards based on the cancer stage.
3.3.4.1 Security Model
Security is a very important aspect of TreatQuest®. Patient/user
information needs to be kept confidential under the Health Insurance Portability
and Accountability Act of 1996 (HIPAA) and Health Information Technology for
Economic and Clinical Health of 2009 (HITECH) Act. Personal information can
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be modified by the patient only so that information integrity will be maintained.
This section will discuss the security features implemented in TreatQuest®.
In order to secure the TreatQuest® website, ASP.NET Membership
service database was installed. The ASP.NET Membership service offers
functions like authentication, authorization, user accounts, and user roles. Figure
3-10 is the schema of the Membership database.

Figure 3-10

ASP.NET Membership Database Schema

Using ASP.NET Membership service and the login controls in ASP.NET
gives TreatQuest® a powerful and convenient way to validate users by a database.
The membership service has been implemented in the following four steps. First,
a membership database named aspnetdb is created in SQL Server. Second,
specification of membership option is enabled. Third, the type of membership is
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determined and configured in TreatQuest®. Lastly, user membership account and
configuration roles are defined.
3.3.4.2Authentication via Forms Authentication
Authentication is the process of ascertaining the client's identity. A client
who has been successfully identified is said to be authenticated whereas an
unidentified client is anonymous. A secure authentication system embodies at
least one of the following three facets: something one knows, something one has,
or something one is. Most web applications rely on something the client knows,
such as password or PIN. The information used to identify a user, such as
username and password, is also referred to as credentials.
Forms authentication has been a popular way of securing web
applications. Forms authentication identifies a user by prompting him or her to
enter the credentials through a web form. Consequently, when a user attempts to
access an unauthorized resource, he or she will be automatically redirected to the
login page where credentials can be entered. The submitted credentials are then
validated against a database with the user information.
After the submitted credentials are verified, an authentication ticket will
be created for the user. The ticket is usually stored as a cookie on the client
computer. Subsequent visits to the same website will activate the ticket in the
HTTP request, thereby enabling the web application to recognize the user once
they log in.
Figure 3-11 illustrates the forms authentication workflow from a highlevel vantage point. Notice that how the authentication and authorization pieces in
ASP.NET act as two separate entities. The authentication system identifies who
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the user is or reports the anonymous status. The authorization system then
determines whether the user has access to the requested resource. For the
unauthorized user (such as those attempting to anonymously visit
ProtectedPage.aspx in Figure 3-11), the authorization system will report that the
user is denied access, triggering the forms authentication system to automatically
redirect the user to the login page. Once the user has successfully logged in,
subsequent HTTP requests will carry a forms authentication ticket for the
authorization purpose.

Figure 3-11: The Workflow of Forms Authentication
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3.3.4.3 Authorization, User Account and Roles
In addition to identifying clients, a server may need to limit the resources
or functionalities for certain requests. Authorization refers to the process of
determining whether a particular user should have the authority to access a
specific resource or functionality. A client must have a user account in order to
access the protected pages in TreatQuest®. A typical user account includes the
information a user needs to log in and use a system. A user account stores
persistent information about a particular user. It must minimally include
information that uniquely identifies the user, such as the user's login name and
password. Along with this essential information, user accounts may include things
like the user's email address, the date and time the account was created, and the
date and time last logged in. In TreatQuest®, user account information is stored in
a relational database at backend by Microsoft SQL Server.
Web applications that support user accounts may optionally group users into
roles. A role is simply a label that is applied to a user and provides an abstraction
for defining authorization rules and page-level functionality. For example, a
website might include an administrator role with authorization rules that prohibit
anyone but an administrator to access a particular set of web pages. Moreover, a
variety of pages that are accessible to all users (including non-administrators) may
display additional data or offer extra functionality when visited by users in the
administrator role. This way, authorization rules can be defined by role rather than
by user. In TreatQuest®, administrators and the public are the two main roles
specified. Figure 3-12 gives an example of extra functionalities that is offered to
the administrator. The administrator can select a specific user account to make
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changes like role setup, update, and account deletion. As illustrated in figure 3-13,
the administrator of TreatQuest® can easily manage a user account in the system.

Figure 3-12 Functionalities for Administrator in TreatQuest®

Figure 3-13 User Account Management by Administrator in TreatQuest®
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3.3.5 Patient Representation in TreatQuest®
In creating a disease-related profile for each patient, TreatQuest® asks for
demographic information, such as gender, date of birth, diagnosis time, staging
information (e.g., tumor size, lymph node, metastasis, and staging code),
histology information (e.g., histology code and cancer type). Figure 3-14
illustrates all the patient information collected by TreatQuest®. This information
serves two important roles. It describes each patient and the disease. It also
functions as the key filters in analytical services, such as accessing the similar
cases in public data.

Figure 3-14 Patient Information Collected by TreatQuest®
The patient information is stored in patient table. Figure 3-15 depicts how
a fictitious patient is represented by a unique database record.
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Figure 3-15 The Tabular Database Representation of Patient

3.3.6 Personalized Patient Information
TreatQuest® puts patients at the center of system design and information
delivery. Its main goal is to furnish patients with sufficient high-quality
information so that they can have greater power, protection, and choice in the key
aspects of their healthcare. Practically, patients are also expected to be better
prepared for treatment procedures and surgeries after using the system.
TreatQuest® provides both general and specialized information. The
general information includes: education material, disease statistics, general
questions to the doctor, test procedures, staging information, and frequently asked
questions and answers. Specialized information includes similar cases analytical
information, standard treatment options based on staging, nomogram and
guidelines. This type of information is tailored to the unique situation of each
patient. For example, the similar case information will show what treatments the
patients with the similar situation in the past have used and how effective they
turned out to be.
3.3.6.1 Similar Cases Treatment Options
TreatQuest® conducts similar cases search by analyzing large-scale public
data. When a patient query is received, the system will retrieve the SEER data
using information from the patient profile. Analysis results will be generated and
aggregated before sending back to the patient. Specifically, treatment options,
total patient count, percentage of patients using the selected treatment and
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survival information will be computed and reported. Figure 3-16 is a screenshot
of TreatQuest® similar cases analysis based on the SEER data from 2004 to 2006.

Figure 3-16 Similar Cases and Treatment Information Given by TreatQuest®
Assume a patient registered with TreatQuest® who has provided
information on gender, race, age, and staging, and histology. Based on this
profile, patients with similar values on these criteria will be returned. Other than
age, all criteria are defined as exact match. The age match is by group instead. For
example, patients aged from 70-74 are treated as one group and considered as
similar age. For staging information, the query retrieves exactly the same stage.
Exact match was also implemented for tumor size, lymph node, metastasis, and
histology code. Take tumor size as an example. The possible values for tumor size
in the SEER data are T1a, T1b, T2a, T2b, and so on. The similar case inquiries
are based on these exact values. For any item that the user didn’t give a value in
the patient profile, similar case match return all possible cases for that item while
filtering them by other criteria available.
Figure 3-16 show the results of a similar case query using the SEER data
from 2004 to 2006. The first column in the table lists treatment options that
previous patients used. Due to the lack of chemotherapy and other treatment
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information in the SEER data, the available treatment options are surgery only,
radiation only, surgery then radiation, and radiation then surgery. The second
column and third column give the number and percentage of patients receiving
each treatment option accordingly. The survival information for the last few
columns was based on the three year survival rate.
3.3.6.2 Evidence-based Standard Treatment Options by Staging
Evidence-based medicine (EMB) is defined as the best research evidence
combined with clinical expertise and the patient’s values and preferences to select
the appropriate treatment option. The best research evidence means valid and
clinically relevant research, especially from patient-centered clinical research
(Straus, 2005[107]). EMB systematically searches a wide range of medical
journals by applying strict criteria for the validity of research. This practice of
evidence-based medicine requires the application of population-based data to the
care of an individual patient (Doi, 2012 [103]). Evidence-based medicine has
gradually emerged as integration of the best research evidence with clinical
expertise and patient values and preferences and expectations (Eddy, 2005[104]).
In line with EMB, TreatQuest® provides evidence-based information on
treatment options by cancer stage, as illustrated in Figure 3-17. This type of
information is not only displayed with a list of treatment options but is also
supported by evidences from empirical research, clinical expertise, and the
clinical trial from NCI website.
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Figure 3-17 Standard Treatment Options with Evidence-based Information
3.3.6.3 Nomogram for NSCLC Post-Operative Radiotherapy
When first diagnosed with cancer, many patients will ask about their
prognosis with questions like “how long can I live?” or “what is the success rate
of this treatment option?” Doctors usually give the survival rate based on the
location and stage of the tumor. Commonly used statistics include 5-year survival
rate and median survival time. For example, a doctor may tell a patient with early
stage lung cancer that he or she has a 50% 5-year survival rate.
In general, today’s cancer survival rate and median survival time are
estimated from a large group of cancer patients. While these estimates do apply to
the general population, they are not particularly accurate for individual patients,
as they do not include patient-specific information, such as age and disease
conditions. While doctors can make adjustments to their survival time prediction
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by individual differences, it is more accurate to explicitly incorporate these
important factors in the prognostic models. For example, information on tumor
size, lymph nodes, and histology reveal important information about the staging
of the patient, and therefore will be very useful for predicting how well a patient
may respond to a treatment and how long s/he will survive.
The survival prediction tool is designed to help physicians and patients
make treatment or surveillance decisions. One such tool, prognostic nomograms,
is incorporated into the TreatQuest®. This tool makes individualized estimation
of prognosis for non-small cell lung cancer patients. It can help determine
whether there will be benefit from a post-operative radiation therapy, or more
specifically, whether there is benefit from the radiotherapy.
Consider a 70 years old female patient with a tumor size of T3 (which is
smaller than 2 cm from carina, chest wall, diaph) and the nodal status of N1
(ipsilateral pulmonary or hilar lymph nodes). The cancer type is adenocarcinoma.
Once the patient selects these options in the system, the prognosis will show these
results: predict median survival without radiation therapy as 24 months and
median survival with radiation therapy as 25 months. That is to say, the net gain
from the post-operative radiation therapy is 1 month. As far as predicted 2-year
overall survival, the percentage is 50% without radiation therapy versus 52% with
radiation therapy, or a net gain of 2%. With all these results available, the patient
can weigh the pros and cons to determine the value of the post-operative radiation
therapy to her. Figure 3-18 illustrates this nomogram example.
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Figure 3-18 Nomogram for NSCLC Post-Operative Radiotherapy
3.3.7 Guidelines in TreatQuest®
According to Wikipedia, a medical guideline is a document with the aim
of guiding decisions and criteria regarding diagnosis, management, and treatment
in specific areas of healthcare. The term “medical guideline” is synonymous with
clinical guideline, clinical protocol, or clinical practice guideline. Medical
guidelines have been in use for thousands of years throughout the entire history of
medicine. They serve as a guide for doctors to use appropriate methods of
treatment and care. They embody the most reliable knowledge base that is
produced or endorsed by a national, provincial, or territorial medical or health
organization, professional society, government agency, or expert panel.
Guidelines can address specific clinical situations (disease-oriented) or use of
approved medical products, procedures, or tests (modality-oriented). Guidelines
define the role of specific diagnostic and treatment methods in the diagnosis and
management of patients.
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Modern clinical practice guidelines identify, summarize, and evaluate the
highest quality evidence and most current data on prevention, diagnosis,
prognosis, and therapy. They also define the most important questions in clinical
practice and identify all possible solutions. They represent summarized consensus
statements based on an examination of current evidences within the paradigm of
evidence-based medicine.
It has been demonstrated repeatedly that the use of guidelines is an
effective way of improving many aspects of healthcare outcome, such as
standardizing medical care, raising quality of care, and reducing risk. Although
healthcare providers are obliged to know the clinical practice guidelines and use
them in treatment, not all clinical practice guidelines have been routinely followed
(Gina, 2004[105]). One way to increase the use of the guidelines is to introduce
them to the patients so that they can also use that knowledge in their decision
making.
3.3.7.1 ACCP Guidelines® for Patient (Small Cell Lung Cancer)
The American College of Chest Physicians (ACCP) has provided clinical
practice guidelines for many years. Over the last several years, their efforts have
been supervised by the ACCP Guidelines Oversight Committee (GOC) to ensure
that the guidelines move as closely as possible to an evidence-based platform.
Consequently, the guidelines provide the best available evidence-based
recommendations for many clinical topics. The ACCP guidelines were
incorporated in TreatQuest® as a PDF file. Figure -19 is the screenshot of ACCP
Guideline for Small Cell Lung Cancer in TreatQuest®.
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Figure 3-19 ACCP Guideline for Small Cell Lung Cancer Screenshot
This ACCP guideline for small cell lung cancer contains information and
knowledge from many different aspects. For patients, the most interesting
information is the intervention and practices sections, which specifies the routine
staging procedure and treatment related information. This guideline also describes
the methodology used to collect/select the evidences, such as those based on the
systematic review of the literature from peer-reviewed journals. This will help
patients understand the major benefits in using clinical practice guidelines.
3.3.7.2 NCCN Guidelines for Patients® (Non-Small Cell Lung Cancer)
The National Comprehensive Cancer Network® (NCCN®) recognizes the
increasing information needs of patients and has created a patient-friendly version
of the NCCN Guidelines, which provides state of the art cancer treatment
information in easy-to-understand language. The NCCN Guidelines for Patients®,
based on the world-renowned NCCN Clinical Practice Guidelines in Oncology
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(NCCN Guidelines®) for cancer care professionals, are meant to help cancer
patients and their families better understand cancer and to prepare them to
communicate better with physicians on treatment options. Since 2011, The NCCN
Guideline for Patients® on Non-Small Cell Lung Cancer has been a very
informative educational tool for both physicians and patients.
3.3.7.3 NCCN Guidelines for Patient® representation in TreatQuest®
(Treatment Wizards for Non-Small Cell Lung Cancer)
Based on the NCCN Guidelines for Patients® of Non-Small Cell Lung
Cancer Version 1.2012, different treatment wizards were implemented in
TreatQuest®. Based on the stage of non-small cell lung cancer, the guidelines
were divided into ten treatment wizards and one test wizard. Depending on the
stage of the NSCLC, different treatment process flow will be given to the patient.
The process flow is based on test results, health condition, surgery result, and
other conditions.
Unlike the paper brochure, the treatment wizards in TreatQuest® are able
to provide customized information to patients. Using interactive means to retrieve
information and knowledge, the guidelines are presented in a simplified way.
More specifically, the Treatment wizards simulate the step by step process flow of
a guideline. The wizard-based interface allows the guideline to be implemented as
a series of navigation steps. For each step, ASP.NET wizard control is used to
collect user’s input and build forms. Based on user’s data for the current step,
different options are presented for the next step so that the user can choose which
direction to go.
An example of how NCCN guideline is represented in TreatQuest® is
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described below. Figure 3-20 is a specific NCCN guideline for Stage IV NonSmall cell lung cancer. For this guideline, it is divided into a series of steps. The
first step is getting the performance status score of the patient. Based on that
score, the second step is to provide information on the first-line treatment. The
third step is getting the treatment response for the first-line treatment during first
two treatment cycles. Depending on the response, the last step is offering
treatment options after the first-line treatment.

Figure 3-20 Staging IV Widespread Squamous Lung Cancer Guideline
example from NCCN Guidelines for Patient of NSLC
How the TreatQuest® treatment wizards actually implements the above
guideline is demonstrated below. The guideline rule is specified as: “For Stage IV
widespread squamous lung cancer patients, offer chemotherapy as first-line of
treatment if the performance status score is 2. Then, if there is no cancer growth
during the first two chemotherapy cycles, continue for 4-6 chemotherapy cycles.
If there is cancer growth in those chemotherapy cycles, re-evaluate the
performance status score. If the score falls between 0 and 2, Docetaxel,
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Pemetrexed, Erlotinib, best supportive care, or clinical trial, will be given as the
treatment option after first-line treatment.” Figure 3-21 is the screen shot of the
first step in the wizard. Figure 3-22 shows how the patient can obtain more
information on treatment options. Both figures clearly demonstrate how the
guideline is implemented in an interactive mannerin TreatQuest®.

Figure 3-21 Collect performance score using treatment wizard of Stage
IV Non-Small Cell Lung Cancer in TreatQuest®
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Figure 3-22 First-line treatment given using treatment wizard of Stage IV NonSmall Cell Lung Cancer in TreatQuest®
3.3.8 Customized Search in TreatQuest®
TreatQuest® provides customized search functions to help patients to
obtain evidence-based information from major cancer information websites.
Using the customized search function, patients can easily retrieve accurate and
updated information from major cancer sites right away. By adapting the Google
custom search engine, TreatQuest® users can search across a set of credited sites,
which are : MedlinePlus website (http://www.nlm.nih.gov/medlineplus/),
National Cancer Institute at the National Institutes of Health website
(http://www.cancer.gov), National Comprehensive Cancer Network website
(http://www.nccn.org), WebMD website(http://www.webmd.com), US National
Library of Medicine’s search service PubMed website
(http://www.ncbi.nlm.nih.gov/pubmed), and ScienceDirect
website(http://www.sciencedirect.com). The following section will give a brief
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introduction of each site and what benefits they bring to TreatQuest®.
MedlinePlus
MedlinePlus® is a high-quality gateway to consumer health information
from the National Library of Medicine(NLM), the National Institutes of Health
(NIH), and other authoritative organizations. MedlinePlus® was rated by some
researchers as the gold-standard web-based consumer health information site
(Schloman, 2006 [106]).
MedlinePlus was first released by NLM in 1998. As a government-owned
web site, MedlinePlus has offered free service with no advertisements. The site
also uses no cookies and requests no personal information. Information at
different levels can be requested to meet different needs of patients and families.
For example, for users who like to know more research findings, MedlinePlus®
integrates PubMed/MEDLINE searching engine for peer-reviewed biomedical
journal citations on the Health Topic pages. As another example, for patients
coping with a serious or chronic illness, MedlinePlus® can retrieve articles,
evidence-based medicine, and consensus practice guidelines. Each MedlinePlus®
Health Topic page features a link to the institute with primary research
responsibility on certain disease. Users can follow the links to obtain additional
information.
NCI
The National Cancer Institute (NCI), a component of National Institutes of
Health(NIH), is the federal government's principal agency for cancer research and
training. The NCI was established under the National Cancer Act of 1937.The
Public Health Service Act charged NCI with continuing and expanding programs
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to provide physicians and the public with state-of-the-art information about the
treatment of individual types of cancer and to identify clinical trials that might
benefit patients while advancing knowledge of cancer treatment. The National
Cancer Act of 1971 broadened the scope and responsibilities of the NCI and
created the National Cancer Program, which supports research, training, health
information dissemination, and other programs with respect to the cause,
diagnosis, prevention, and treatment of cancer. The program also provides the
supportive care of cancer patients and their families.
The NCI website provides accurate, up-to-date, comprehensive cancer
information, hence it is treated as one of the core web sites used by TreatQuest®
that help patients acquire cancer information.
NCCN
The National Comprehensive Cancer Network (NCCN) is a nonprofit
alliance of 21 cancer centers throughout the U.S. Experts from NCCN cancer
centers diagnose and treat all cancers, with a particular focus on complex,
aggressive, or uncommon cancers. NCCN developed the NCCN Clinical Practice
Guidelines in Oncology, a set of recommendations designed to help health care
professionals diagnose, treat, and manage cancer patient care. Additionally,
NCCN launched its new series of NCCN Guidelines for Patients™, a consumerfriendly translation of the NCCN Guidelines. The first two guidelines released
cover breast and lung cancers.
NCCN's flagship website, NCCN.org, is geared toward health care
professionals. It provides them with access to the NCCN Clinical Practice
Guidelines in Oncology (NCCN Guidelines®). NCCN.com is the consumer

72
website that provides the same information as the NCCN.org. Both NCCN
websites are included in the core list of web sites used by TreatQuest® so that
patients can conduct customized search for high quality cancer treatment
information.
WebMD
WebMD Health Services provides private health management programs
and benefit decision-support portals to employers and health plans. WebMD is
primarily known for its public website, which has a huge amount of information
on health and health care, such as symptom checklists, pharmacy information,
drug information, blogs of physicians with specific topics, and a place to store
personal medical information. The WebMD website is a leading health portal in
the United States. Since 2001, most WebMD’s operations have been accredited
by URAC, the largest accrediting body for health care. In addition to the WebMD
site itself, the WebMD Health Services also operate other health-related websites,
such as MedicineNet, Medscape, eMedicineHealth, and RxList. WebMD is
included in the core list of websites that patient can search via TreatQuest®.
PubMed
PubMed website is an online retrieval service developed by the National
Center for Biotechnology Information (NCBI) at the National Library of
Medicine (NLM). PubMed offers free access to MEDLINE, a database of over 10
million bibliographic citations, indexed citations and abstracts to medical,
nursing, dental, veterinary, health care, and preclinical sciences journal articles.
PubMed also contains links to the full-text versions of articles at participating
publishers' web sites, biological data and sequence centers from third parties.
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Moreover, PubMed grants access and links to the integrated molecular biology
databases maintained by NCBI. Apparently, adding PubMed into the core list of
website in TreatQuest® greatly enhances the capacity of users in retrieving
research articles.
ScienceDirect
ScienceDirect is one of the world's leading sources of scientific, technical,
and medical research. It is a full-text database offering articles and book chapters
from more than 2,500 peer-reviewed journals and more than 11,000 books. There
are currently more than 11 million articles/chapters, a content base that is growing
at a rate of almost 0.5 million per year. The ScienceDirect platform offers
sophisticated search and retrieval functions that enable users to maximize the
effectiveness of their knowledge discovery process. For example, by setting the
filter with lung cancer, users can retrieve research papers in this specific area.
ScienceDirect is incorporated into TreatQuest®.
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Chapter 4 Evaluation and Results
4.1 Introduction
As a discipline, human-computer interaction (HCI) is concerned with the
design, evaluation, and implementation of interactive computer systems for
humans. Such systems can be evaluated with respect to many different aspects,
for example, functionality, reliability, usability, efficiency, maintainability, and
portability. Due to the explosive growth of interactive software in the last decade,
usability has gained prominence in system evaluation. Accordingly, our focus in
evaluating the TreatQuest® system will be on its usability.
Different definitions of usability have been proposed. Shackel (Shackel,
1991[107]) defines usability of a system as “the capability in human functional
terms to be used easily and effectively by the specified range of users, given
specified training and user support, to fulfill the specified range of tasks, with in
the specified range of environmental scenarios”. One standard definition is
provided by the International Organization of Standards (ISO). The ISO 9241-11
standard, also titled Ergonomic requirements for office work with visual display
terminals, states that “usability of a product is the extent to which the product can
be used by specific users to achieve specific goals with effectiveness, efficiency,
and satisfaction in a specific context of use.” This definition underlines that for a
system to be usable, users should be able to achieve its functions with
considerable ease. While the ISO 9241-11 recommendations have become the
standard in the usability research, the most widely adopted definition of usability
in system evaluation is the one introduced by Nielsen (Nielsen,1993[108]). It
provides a detailed model in terms of usability constituents, hence it is more
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suitable to be objectively and empirically verified by different evaluation
methods. The Nielsen’s definition of usability is comprised of the following five
components:
1. Learnability: the ease of learning the functionality and the behaviors of the
system.
2. Efficiency: the level of attainable productivity once a user has learned the
system.
3. Memorability: the ease of remembering the system functionality. This
refers to how easily a casual user can return to the system after a period of
non-use.
4. Few errors: the capability of the system to feature a low error rate, to
support users making fewer errors in using the system, and in case an error
is made, to help them to recover easily.
5. User satisfaction: the level users find the system pleasant to use.
4.2 Evaluation Methods
The usability of a system can be evaluated by multiple techniques and
methods. Three types of usability evaluation methods are empirical method,
inspection method, and inquiry method. The empirical method is user-oriented. It
is based on the systematic evaluation of users’ experience with a system. The
inspection method, on the other hand, is specialist-oriented. A specialist, such as
a software developer, can examine the usability-related aspects of a user
interface. The inquiry method focuses on the interaction between users and
professionals. A specialist may ask a user how he or she likes, dislikes, and
understands the system by oral and written communication. A specialist may also
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observe how a user actually uses the system in real work. Table 4-1 summarizes
the methods used by the above three evaluation categories.
Table 4-1 Usability Evaluation Methods
Method Category

Inquiry Method

Empirical Method

Inspection Method

Methods
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o

User satisfaction questionnaire
Field observation
Focus group
Interviews
Thinking aloud method
User performance test
Remote usability test
Beta test
Forum test
Cooperative evaluation
Coaching method
Expert review
Heuristic evaluation
Cognitive walkthrough
Pluralistic walkthrough
Structured heuristic evaluation
Perspective-based inspection

Since the inquiry method tends to identify broad usability problems and to
seek opinions about the systems as a whole, it was used in evaluating the
TreatQuest® system. In applying this method, a web-based user satisfaction
questionnaire was developed to seek the feedback from patients. Field
observation was also conducted to evaluate the system.
4.3 Determining the Number of Users to Test
While the common wisdom may favor a large number of users to test the
system, Nielsen has argued against that approach, as to him, elaborate usability
tests is too costly and acceptable results can be achieved from as few as 5 users
(Jackob,1993 [109]). A mathematical model has been established for computing
the exact number of users in usability tests (Jackob and Landauer, 1993 [110]).
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The model is

K= N (1 − (1 − λ )i )

(EQ4.1)

where N is the number of questions to be evaluated, λ is the probability that one
subject is able to find the average problem, and i is the number of test subjects.
This model can also be illustrated by curves over a common range of λ values, as
in Figure 4-1.

Figure 4-1 Relationship between Number of Test Users and Proportion of
Usability Problems Found
Based on a large number of experiments, Nielsen (Nielsen, 1993 [111])
pointed out that the average proportion of usability problems discovered by a
single user is about 31%. Using that as the estimate of the λ value in the figure,
we would need about 15 users to discover all the usability problems. These 15
users could be selected by two steps: the first 5 users to identify the initial
problems in the design and the next 10 users to validate the identified problems
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and to look for new ones.
4.4 Data Analysis and Result
4.4.1 Data Collection
The data for evaluating TreatQuest® was collected from lung cancer
patients who have used the system. The newly diagnosed lung cancer patients
from Columbia St. Mary’s Cancer Center in Milwaukee were contacted to
participate in the study.
Once a patient filled out the consent form, a training session was arranged
to help the patient familiar with the TreatQuest® system. The training provided
an overview of the system, demonstrated how to use the system, and finally
helped the patient to setup an account and to create profile in the TreatQuest®
system. Meanwhile, the nurse coordinator from the at Columbia St. Mary's
Cancer Center helped the patient to prepare a disease profile in the TreatQuest®.
Once the patient or their family member had an account with TreatQuest®
system, they could start to use the system. After using the TreatQuest® for a
period of time (e.g., a month), the patient would be asked to fill out a survey to
evaluate the system.
4.4.2 Observation during Training
At each training session, I observed how the patient and their family
members interacted with the TreatQuest® system. Their comments on the general
features as well as specific functions were recorded and analyzed. Table 4-3
provides some observation during training session.
In general, patient and/or their family members were interested in the
value that TreatQuest offers. They indicated that the system was easy to use and
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not hard to navigate and find information. No patient or family members
considered themselves as computer savvy, but they expressed that the system was
user-friendly.
4.4.3 Survey and Survey Data
The main goals in evaluating the TreatQuest® system were to conclude
how well the prototype system actually performs and also to explore how the
users like the system. To achieve that, both qualitative and quantitative data were
collected. The quantitative data came from the numerical rating in answering the
likert-scale questions on an online patient survey. The qualitative data, on the other
hand, were based on the narratives that users provided in answering short-answer
questions. These answers helped to delve into more depth of user satisfaction.
A patient survey was conducted to identify whether the system has
achieved its goals, what problems users still encounter, and what
recommendations users have for improving the systems. By adapting the aforementioned Nielsen’s definition of usability to a decision support system like
TreatQuest®, the survey covered the following 6 areas: ease of use, learnability,
information facilitation (i.e., how quickly patients can locate information), look
and feel consistency (e.g., how the pages look and feel), content of the site (e.g.,
whether the content will keep patients coming back), and finally, site
organization.
As shown in Appendix I, the whole survey has 40 items which were
arranged in three parts. The first part asks for demographic information, such as
education level and attitude towards Internet use for healthcare system. The
second part consists of questions on specific TreatQuest® functions such as
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treatment wizard and search. The final part asks questions on the overall
impression of the system, such as how easy it is to use and navigation the
system.
Survey questions were written in the format of Likert scale. Participants
were asked to indicate the degree of agreement with the statement on a five point
agreement scale. These statements had been carefully selected to measure users’
perception and attitudes toward the benefit of using the TreatQuest®. Figure 4-2
gives an exemplary item. Short-answer questions were also included in the
survey to collect more open-ended response on some aspects of the system.

Figure 4-2 Survey Question Example
In practice, a patient was first introduced to the system by the developer.
Then the patient filled out a survey to indicate the satisfaction level after using the
system for a period of time (eg. a month). As discussed above, their answer to the
40 items on the survey provided plentiful data on the core functions of the system,
such as access to knowledge resources, decision support, as well as usability, such
as intent to use and user satisfaction.
4.4.4 Preliminary Evaluation Results
Altogether seven patients completed the evaluation study. Their
demographic information was in Table 4-2. While a small sample, they did
represent quite a diverse group. As shown in the table, they represented different
genders, races, age groups, and stages. Two patients are female, the others
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patients are male. The races of the patient included both white and black. The age
of those patients range from 54 to 79.
Table 4-2 Characteristics of Patient Samples
Characteristic
Gender
Male
Female
Age Group
50-54
55-59
60-64
65-69
70-74
75-79
Race/ethnicity
White
Black
Stage at Diagnosis
Stage II
Stage III
Stage IV

Number of Patients (Percentage of Patients)
5 (71%)
2 (29%)
1 (14%)
1 (14%)
2 (29%)
2 (29%)
1 (14%)
6 (86%)
1 (14%)
1 (14%)
2 (29%)
4 (57%)

4.4.4.1 Field Observation Results
In general, the feedback has been extremely positive. Most patients
indicated that TreatQuest® website was clear, straightforward, and easy to find
the treatment-related information. More importantly, patients were enthusiastic
about the value TreatQuest® provides to them. For example, at the end of one
training session, one couple commented: “Thank you very much to put together
such valuable system to provide valuable source of information and knowledge.
We are certainly looking for second opinion and want to learn more information
and knowledge.” Table 4-3 complies the users’ comments by topic.
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Table 4-3 User's Comments
On Education Materials:
o This information is very helpful. Can you print this for me now? Some of
those questions are exactly what we want answered.
o I want to check with the nurse to see if they have any brochure like this.
o It is always nice to have the glossary of terms. You might want to know
the meaning of some terms.
On Treatment Wizards:
o I think this will add to our knowledge. I'll check whether my husband had
done tests listed here.
o The information about the surgery type in the wizard is useful.
On Similar Cases and Treatment Used
o It is good to have similar cases information although chemotherapy and
target therapy information are not available
o Physician is considering surgery; the information about the surgery type is
good to have.
On Treatment Options and Evidences:
o A lot of information presented here. I have to find time to go through.
o Let's skip the statistics numbers
On Nomogram
o Which histology I should choose? What is the net benefit?
From FAQs
o It is convenient to have FAQs.
On Search function
o It is neat to have the search function and integrate all those information
together.
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4.4.4.2 On-line Survey Results
Out of the seven patients who received the training of the TreatQuest®
system, five provided survey responses. Regarding their background, four
received higher education. All of them indicated that they were frequent internet
users. About 60% of them indicated that they did use internet to search for health
or medical information. They all expressed that they felt comfortable to use
information from internet to communicate with their physicians. Along with that,
they all agreed that the external information could help them to make
health/treatment related decisions. With regard to the information provided by
their physicians, while some thought it was enough, others were looking for a
second opinion.
Regarding the information provided by the TreatQuest® system, their
response varied by topic. All patients agreed that education material in
MyTreatQuest was informative and could potentially help them to communicate
with a physician. They either agreed or strongly agreed with the statements that
Treatment Wizard can provide a helpful guide, clear explanation and information
that they are looking for and treatment wizard is helpful in discussing my
treatment options with a physician. For information presented to patients, they
indicated that similar cases and treatment used based SEER data were informative
and would help them in making treatment decisions or communicating with their
physicians.
All patients were satisfied with the information provided from the “Your
Treatment Options and Evidences Based on NCI” part. However, some patients
were uncertain about Nomogram functions. Also, surprisingly, not all patients
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were in favor of the statistics information provided by the TreatQuest®. Some of
them tried to skip that during the training session. But both the Frequently Asked
Questions and Questions to Ask My Doctor sections were deemed informative to
all patients.
In general, patients found the TreatQuest® website easy to use and
navigate. All patients agreed that the content is well organized, and website gives
a consistent look and feel. Most of the patients (80%) agreed that the TreatQuest®
website contains mostly the treatment related information that they are interested
in and it also provides evidence-based information to help them make treatment
decisions. Eighty percent patients indicated that they were very likely to
recommend the website to other patients in the future.
In the survey responses, some patients also listed other website they were
using to find lung cancer-related information. One example is the
www.MayoClinic.com. Some patient suggested adding diagnosis related
information to TreatQuest® website. As far as the information that most affected
their treatment decision, some chose side effects; some chose to prolong the
overall survival; the majority chose doctor’s opinion.
Overall, the survey results show that TreatQuest® performed well to offer
evidence-related information to patients, and could play an important role in
helping patients to make treatment-related decisions. The complete survey results
can be seen in Appendix F.
4.5 Physician Inputs and Opinions
During the phase of design and testing of the TreatQuest® system, the
physicians and nurses of Columbia and St. Mary’s hospital not only verified the
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system but also offered valuable suggestions on how to further improve the
system. Examples of those suggestions were:
•

limit the histology code so that it is simple to use when patients
enter their profile information

•

add illustrative pictures to the treatment wizard for different stages
so that users have a better idea of what “stage” means

•

add more detailed specification on the origin of clinical trials, add
the glossary of term and

•

remove the cancer risk calculator as patients have already been
diagnosed with lung cancer.

All these suggestions have been implemented on TreatQuest® and the
system has become more user-friendly.
All physicians and nurses from Columbia St. Mary’s hospital involved
with this study were in favor of the system. They also shared the latest research
information in this area with the researchers. To them, TreatQuest® system is
valuable to lung cancer patients due to its ability to help patients better understand
treatment options, thus more ready to make a collaborative medical decision.
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Chapter 5 Discussion
5.1 Conclusion
According to a recent Pew Internet & American Life report Project (Fox
and Duggan, 2013[112]), 59% of U.S. adults indicated that they had looked for
health information online in the past year and 35% had gone online specifically
for figuring out the medical condition they or someone else might have. The
report also found that the health information seekers were action-oriented and
highly purposeful. These finding are somewhat surprising as most of these people
have already received information from their physicians and healthcare givers. It
is noticeable that patients and their family members join the stream of information
pathway. One way to help these consumers is practicing consumer-centered
health informatics.
As a relatively young field, consumer health informatics has the potential
to provide frameworks and strategies for designing effective health
communication tools that empower users and improve their health decisions
(Keselman et al., 2008[113]). It provides services in patient-focused informatics,
health literacy, and consumer education. It is devoted to informatics from the
consumer or patient perspective. This new approach requires us to analyze
consumers' needs for information, study and implement methods for making
information accessible to consumers, and model and integrate consumers'
preferences into health information systems.
This dissertation advanced the consumer informatics field by contributing
one solution, the TreatQuest® system. The overall goal in designing this patient
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decision support system was to improve the quality of decision making for
patients. This has been achieved by using evidence-based knowledge and largescale data and building in inquiry functions to provide patient-tailored
information. As a web application, the system is always available to patients. By
following the software development cycle and web design principles, the system
is stable and highly user-friendly. Using this system, patients can generate indepth insights into the decision process. They can educate themselves about the
disease, compare different treatment options and their outcomes, and study the
implications of their preferred treatment. Hopefully, a DSS like this will play a
key role in the decision process of many patients.
This dissertation research provides many insights on how to design an
effective patient decision support system. The prototype was set up to help lung
cancer patients to access evidence-based information and knowledge. The design
can be easily applied to develop systems focused on other diseases. The key
components for the systems include high-quality large-scale data source and
analytic tools, industry guidelines and other knowledge bases, interactive search
functions, user friendly interfaces, and web application. When these components
are synthesized into a system, patients have a reliable resource to seek highquality information. The system evaluation results show that the use of
TreatQuest® can actually help patients obtain the targeted information and
enhance communication with physicians to achieve shared decision making.
5.2 Limitations of the Study
Several limitations exist for the current study. First, treatment information
is limited to what is available from the SEER data. As commented by patients in
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the evaluation study, no chemotherapy and target therapy information are
included in the system, hence users will not be able to look for similar cases along
those lines, which are actually quite standard treatments. Second, so far,
TreatQuest® does not have the capacity to support all browsers as the system
was built using the Microsoft technology. As the attention has been mainly on
how to build an efficient and stable system, compatibility has not been given
enough care. While most functions are supported in most browsers, there are
functions that do not work as designed in some browsers. Third, the sample
size for system evaluation is small. While tremendous effort has been put into
recruiting by me and my advisor, and the hospital had been very cooperative, the
data collection has taken much longer than expected, the sample size was still
quite small, maybe due to the following reasons. First, the number of lung cancer
patients a hospital treats is limited. Second, many patients are not willing to
participate in a research study, which is understandable, considering their
health status. Even for those who participated, not all of them return the survey
results. The small number of responses limits our ability to draw any significant
conclusions. Though they did provide many insightful, usually positive,
comments about the usability of the system, no usability or performance
problems were identified.
Newly diagnosed older lung cancer patients who have lived into later years of life
may have concurrent ailments (e. g, diabetes, chronic obstructive pulmonary disease, heart
disease, arthritis, and hypertension). In other words, they usually have multiple health
problems. Those comorbidities could affect treatment choice, prognosis, and survival
since comorbidity has an important impact and greatly increases the complexity of
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managing disease in patients. TreatQuest® will not able to give all guidelines and
treatment information for those complicated cases. The guidelines given by the
system will not address how other comorbidities may inﬂuence the treatment
decisions and the cancer course either.
5.3 Future Directions
The first direction is to extend the prototype to other types of cancer.
While lung cancer is the most popular cancer, patients of other types of cancer
need as much help. One critical step in the extension is to locate the high-quality
data source, such as the SEER-Medicare data. In addition, industrial guidelines
are also helpful. The other important aspect is to understand the needs of patients.
One feature that can be expanded is the survival prediction function. The
current system took advantage of a module to conduct survival prediction
analysis. Future research can work on building a more customized survival model
based on the population data.
Another direction for future research is to extend the system to mobile
devices. One important feature of a decision support system like TreatQuest® is it
is available all the time. Though mobile devices have been adopted to deliver
many health services (Wu et al., 2005 [114]), how suitable they are for a patient
decision support system is unclear and asks for further study. This direction can
also include to expand the social networking features in the system. Social
networking technology is shaping how people and organizations interact and
share information. Studies can be designed to understand how social networking
impacts patient decision making as well as how to integrate social networking in
the decision support system.
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Appendix E: TreatQuest® User Survey
First, we want to thank you for participating in this survey about the TreatQuest
website.Your responses will be kept strictly confidential and be used for research
purpose only. Only aggregated group level will be reported.
This survey will ask questions on how you like the TreatQuest website. To answer
a question, please click the option following each question which best describes
your situation. We are looking for your honest opinion on how this website may
be able to help patients like you. The survey takes about 10 to 20 minutes. Your
participation in this study is comorbiditypletely voluntary. If you have questions
about the survey, please contact Dr. Hemant Jain at 414-229-4832 or by email at
jain@uwm.edu. Your feedback will help developer of TreatQuest improve this
website to better serve more users like you in the future.
Part I Questions about your background
1. What is the highest level of your education?
a) Doctoral Degree
b) Master Degree.
c) 4-Year College
d) 2-Year College
e) High School
f) Less than High School
g) Other
2. How often do you use the internet?
Very Often like on daily basis
Often like few times a week
Occasionally like once or twice a month
Seldom like once or twice a year
Never like not use it at any place
3. Do you use the internet to search for health/medical related information?
Yes
No
Not Applicable
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4. How comfortable do you feel using information from the internet to
communicate with a physician?
Very comfortable
Comfortable
Not comfortable
Not use internet information at all
5. Do you agree that information from the internet can help you make
health/treatment related decisions?
Strongly agree
Agree
Uncertain
Disagree
Strongly disagree
6. Do you think information provided by a physician is sufficient?
Strongly agree as they are experts.
Agree
Uncertain
Disagree. I sometimes look for a second option. .
Strongly disagree. I always look for a second option
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Part II Questions about My TreatQuest
The following statements describe specific features of My TreatQuest page that
you have reviewed. Please indicate how they describe your experience by
selecting from the five agreement levels.
Strongly
agree

Agree

Uncertain

Disagree Strongly
disagree

7. Education material in My
TreatQuest page is very informative.
8. Education material in My
TreatQuest page can help me
communicate with a physician?

Part III Questions about Treatment Wizards
The following statements describe specific features of Treatment Wizards page
that you have reviewed. Please indicate how they describe your experience by
selecting from the five agreement levels.
Strongly Agree Uncertain Disagree Strongly
agree
disagree
9. The Treatment Wizards provided a
helpful guide to my treatment options.
10. Each step in the Treatment
Wizards gave me sufficiently clear
explanation.
11. By using the Treatment Wizards,
I was able to find the exact information
that I was looking for.
12. The Treatment Wizards was
helpful in discussing my treatment
options with a physician.
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Part IV Questions about Information for Patient
The following statements describe specific features of Information for Patient
page that you have reviewed. Please indicate how they describe your experience
by selecting from the five agreement levels.
Strongly Agree Uncertain Disagree Strongly
agree
disagree
13. On the Information for Patient page,
the Similar Cases and Treatments Used
section helped me make treatment–
related decisions.
14. On the Information for Patient page,
the Similar Cases and Treatments Used
section helped me communicate about
treatment options with a physician.
15. On the Information for Patient page,
the Similar Cases and Treatments Used
section is informative.
16. On the Information for Patient page,
the Your Treatment Options and
Evidences section is informative.
17. On the Information for Patient page,
the Your Treatment Options and
Evidences section helped me
communicate with a physician in regards
to treatment options.
18. On the Information for Patient page,
the Your Treatment Options and
Evidences section helped me make
treatment decisions.
19. The Nomogram tool is an
informative tool to use.
20. The Nomogram tool helped me
communicate with a physician.
21. The Nomogram tool helped me
make treatment decisions.
22.On the Information for Patient page,
the Statistics section is very informative.
23. On the Information for Patient page,
the Frequently Asked Questions and
Answers is useful.
24. On the Information for Patient page,
the Questions to Ask My Doctor section
helped me communicate with a
physician.
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Part V Questions about Search and other functions
25. The Search function at the top of each page is easy to use.
Strongly agree
Agree
Uncertain
Disagree
Strongly disagree
26. The list of websites in the Search functionincluded all the major websites
related to lung cancer.
Strongly agree
Agree
Uncertain
Disagree
Strongly disagree
27. What are the other websites you use to look for lung cancer-related treatment
information?

28. On the Knowledge Resources page, the similar case search criteria are easy
to understand.
Strongly agree
Agree
Uncertain
Disagree
Strongly disagree
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29. On the Knowledge Resource page, which section was the most helpful for
your treatment decision?
Similar Cases and Treatments Used Based On SEER Data
Treatment Option from NCI
Statistics
Guidelines
Nomogram
Part VI Questions about TreatQuest website in general
Strongly Agree
agree
30. TreatQuest website is easy to use.
31. Navigating the TreatQuest website is
easy.
32. The content of the TreatQuest
website is well organized.
33. The TreatQuest website has a
consistent look and feel.
34. TreatQuest website contains most
treatment related information that I’m
interested in.
35. The evidence-based information that
TreatQuest provided helped me to make
decisions regarding my treatment
options.

Uncertain Disagree Strongly
disagree

36. How likely are you to recommend TreatQuest to a patient or family member
of a patient in the future?
Very likely
Somewhat likely
Unlikely
37. How likely are you to use TreatQuest as your primary source for getting
treatment related information?
Very likely
Somewhat likely
Unlikely
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38. Do you want other non-treatment related information, such as diagnosis and
risk factor, to be included in the TreatQuest website?
Yes
No
39. Regarding your treatment decision, what kind of information affected you the
most?

40. What changes or additional features would you suggest for this website?

End of the survey. Thanks for your feedback.
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Appendix F: TreatQuest®: User Survey Results
Part I Questions about Your Background
1. What is the highest level of your education?
Doctoral Degree

0

0%

Master Degree

1 20%

4-Year College

2 40%

2-Year College

1 20%

High School

1 20%

Less than High School

0

0%

Other

0

0%

2. How often do you use the internet ?
Very Often, like on daily basis

2 40%

Often, like few times a week

2 40%

Occasionally, like once or twice a month

0 0%

Seldom, like once or twice a year

0 0%

Never like not use it at all

1 20%

3. Do you use the internet to search for health/medical related information ?
Yes

3

60%

No

2

40%

4. How comfortable do you feel using information from the internet to communicate with a
physician?
Very comfortable

1 20%

Comfortable

4 80%

Not comfortable

0 0%

Not use internet information at all

0 0%

5. Do you agree that information from the internet can help you make health/treatment
related decisions?
Strongly agree

1

20%

Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly disagree

0

0%

6. Do you think information provided by your physician is sufficient?
Strongly agree as they are experts

0 0%

Agree

2 40%

Uncertain

1 20%
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Disagree. I sometimes look for a second option.

2 40%

Strongly disagree. I always look for a second option.

0

Part II Questions about My TreatQuest
The following statements describe specific features of My TreatQuest page that you have reviewed.
Please indicate how they describe your experience by selecting from the five agreement levels.
7. Education material in My TreatQuest page is very informative.
2 40%
Strongly Agree
Agree

3

60%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

8. Education material in My TreatQuest page can help me communicate with a physician.
2 40%
Strongly Agree
Agree

3

60%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

Part III Questions about Treatment Wizards
The following statements describe specific features of Treatment Wizards page that you have
reviewed. Please indicate how they describe your experience by selecting from the five agreement
levels.
9. The Treatment Wizards provided a helpful guide of my treatment options.
3 60%
Strongly Agree
Agree

2

40%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

10. Each step in the Treatment Wizards gave me sufficiently clear explanation.
2 40%
Strongly Agree
Agree

3

60%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

11.By using the Treatment Wizards, I was able to find the exact information that I was
looking for.
0
Strongly Agree
0%
Agree

5

100%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

12.The Treatment Wizards was helpful in discussing my treatment options with a physician.
0
Strongly Agree
0%
Agree

5

100%

Uncertain

0

0%
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Disagree

0

0%

Strongly Disagree

0

0%

Part IV Questions about Information for Patient
The following statements describe specific features of Information for Patient page that you have
reviewed. Please indicate how they describe your experience by selecting from the five agreement
levels.
13. On the Information for Patient page, the Similar Cases and Treatments Used section
helped me make treatment–related decisions.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

14. On the Information for Patient page, the Similar Cases and Treatments Used section
helped me communicate about treatment options with a physician.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

15. On the Information for Patient page, the Similar Cases and Treatments Used section is
informative.
2 40%
Strongly Agree
Agree

3

60%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

16. On the Information for Patient page, the Your Treatment Options and Evidences section
is informative.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

17. On the Information for Patient page, the Your Treatment Options and Evidences section
helped me communicate with a physician in regards to treatment options.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

18. On the Information for Patient page, the Your Treatment Options and Evidences section
helped me make treatment decisions.
1 20%
Strongly Agree
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Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

19. The Nomogram tool is an informative tool to use.
0
Strongly Agree
0%
Agree

4

80%

Uncertain

1

20%

Disagree

0

0%

Strongly Disagree

0

0%

20. The Nomogram tool helped me communicate with a physician.
0
Strongly Agree
0%
Agree

4

80%

Uncertain

1

20%

Disagree

0

0%

Strongly Disagree

0

0%

21. The Nomogram tool helped me make treatment decisions.
0
Strongly Agree
0%
Agree

4

80%

Uncertain

1

20%

Disagree

0

0%

Strongly Disagree

0

0%

22. On the Information for Patient page, the Statistics section is very informative.
0
Strongly Agree
0%
Agree

3

60%

Uncertain

1

20%

Disagree

1

20%

Strongly Disagree

0

0%

23. On the Information for Patient page, the Frequently Asked Questions and Answers is
useful.
0
Strongly Agree
0%
Agree

5

100%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

24. On the Information for Patient page, the Questions to Ask My Doctor section helped me
communicate with a physician.
Strongly Agree

0

0%

Agree

5

100%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%
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Part V Questions about Search and Other Functions
25. The Search function at the top of each page is easy to use.
3 60%
Strongly agree
Agree

2

40%

Uncertain

0

0%

Disagree

0

0%

Strongly disagree

0

0%

26. The list of websites in the Search function included the major websites on which you did
cancer related information research.
1 20%
Strongly agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly disagree

0

0%

27. What are the other websites you use to find lung cancer-related treatment information?
Mayo Clinic
28. On the Knowledge Resources page, the similar case search criteria are clear.
0
Strongly agree
0%
Agree

5

100%

Uncertain

0

0%

Disagree

0

0%

Strongly disagree

0

0%

29. On the Knowledge Resource page, which section was the most helpful for your
treatment decision?
1 20%
Similar Cases and Treatments Used Based On SEER Data
Treatment Option from NCI

2 40%

Statistics

1 20%

Guidelines

0 0%

Nomogram

0 0%

Part VI Questions about TreatQuest Website in General
30. TreatQuest website is easy to use.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

31. Navigating the TreatQuest website is easy.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%
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32. The content of the TreatQuest website is well organized.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

33. The TreatQuest website has a consistent look and feel.
1 20%
Strongly Agree
Agree

4

80%

Uncertain

0

0%

Disagree

0

0%

Strongly Disagree

0

0%

34. TreatQuest website contains most treatment related information that I’m interested in.
1 20%
Strongly Agree
Agree

3

60%

Uncertain

1

20%

Disagree

0

0%

Strongly Disagree

0

0%

35. The evidence-based information that TreatQuest provided helped me to make decisions
regarding my treatment options.
1 20%
Strongly Agree
Agree

3

60%

Uncertain

1

20%

Disagree

0

0%

Strongly Disagree

0

0%

36. How likely are you to recommend TreatQuest to a patient or family member of a patient
in the future?
4 80%
Very likely
Somewhat likely

1

20%

Unlikely

0

0%

37. How likely are you to use TreatQuest as your primary source for getting treatment
related information?
1 20%
Very likely
Somewhat likely

4

80%

Unlikely

0

0%

38. Do you want other non-treatment related information, such as diagnosis and risk factor,
to be included in the TreatQuest website?
3
Yes
60%
No

2

40%

39. Regarding your treatment decision, what kind of information affected you the most ?
side affect, prolong the overall survivalDOCTOR OPINIONphysician's opinion
40. What changes or additional features would you suggest for this website?
NONEnone
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